{"study_id": 186861, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare DHA content in the breast milk of preterm and term mothers and investigate how gestational age affects DHA levels.", "results_summary": "Preterm mothers had lower DHA content in their breast milk compared to term mothers, and each additional week of gestational age was associated with increased DHA levels. The study suggests breast milk may not meet recommended DHA intake for preterm infants.", "population_specificity": "Preterm and term mothers, with breast milk collected 24-96 hours postpartum.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:50.993662+00:00"}
{"study_id": 186860, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of docosahexaenoic acid (DHA) in combination with eicosapentaenoic acid (EPA) for cardiovascular disease prevention in a general population.", "results_summary": "The study found that the n-3 FA intervention did not significantly reduce major cardiovascular events but did reduce total myocardial infarction, percutaneous coronary intervention, fatal MI, and recurrent hospitalization for heart failure. African Americans derived the greatest treatment benefit for MI and recurrent heart failure hospitalization.", "population_specificity": "25,871 US adults aged 50 and older, including 5,106 African Americans.", "effective_dosage": "1 g/day (1.2:1 ratio of EPA to DHA).", "study_duration": "Median of 5.3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:51.579519+00:00"}
{"study_id": 186862, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the efficacy of dietary omega-3 polyunsaturated fatty acids (including DHA) in reducing oxidative stress markers and improving enzymatic antioxidant activities in Alzheimer's disease patients.", "results_summary": "The study found that DHA and EPA supplementation significantly reduced protein and lipid oxidation markers and increased catalase activity in plasma after six and twelve months, while superoxide dismutase activity remained unchanged. No significant changes were observed in the placebo group.", "population_specificity": "Alzheimer's disease patients", "effective_dosage": "Stable dose of DHA and EPA (specific amounts not provided)", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:52.499299+00:00"}
{"study_id": 186865, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the role of omega-3 LCPUFA, particularly docosahexaenoic acid (DHA), in preventing preterm birth and determining gestational length in singleton pregnancies.", "results_summary": "The study found that adequate intake of omega-3 LCPUFA, especially DHA and EPA, in early pregnancy is associated with a lower risk of preterm and early preterm births. Women with low omega-3 levels benefit most from supplementation, with about 1000 mg of DHA plus EPA being effective in reducing early birth risk.", "population_specificity": "Women with singleton pregnancies, primarily in upper-middle or high-income countries.", "effective_dosage": "About 1000 mg of DHA plus EPA daily.", "study_duration": "Supplementation preferably commenced before 20 weeks' gestation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:55.078359+00:00"}
{"study_id": 186863, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether neonatal DHA supplementation in preterm infants (born before 29 weeks' gestation) improves cognitive development, as measured by FSIQ scores at 5 years of age.", "results_summary": "The study found that DHA supplementation was associated with modestly higher FSIQ scores (95.4 vs. 91.9) at 5 years compared to the control group, though secondary outcomes did not consistently support this result. Adverse events were similar between groups.", "population_specificity": "Preterm infants born before 29 weeks' gestation.", "effective_dosage": "60 mg of DHA per kilogram of body weight per day.", "study_duration": "From the first 3 days of enteral feeds until 36 weeks of postmenstrual age or discharge home, whichever occurred first.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:55.430235+00:00"}
{"study_id": 186866, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how omega-3 PUFA supplementation (EPA, DHA, or olive oil) affects plasma levels of TPAn-3 and THA, precursors to DHA, in humans, with a focus on sex-specific differences.", "results_summary": "EPA supplementation significantly increased plasma TPAn-3 (215%) and THA (112%) levels, particularly in women, while DHA supplementation had no effect. Women exhibited higher plasma TPAn-3 and THA levels than men, suggesting greater accumulation of these precursors, which may explain higher DHA levels in women.", "population_specificity": "Women and men aged 19-30 years (n = 10-14 per sex, per diet).", "effective_dosage": "3 g/day of EPA, DHA, or olive oil.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:56.817322+00:00"}
{"study_id": 186867, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether DHA supplementation during pregnancy modifies the effect of prenatal arsenic exposure on the risk of atopic dermatitis in preschool children.", "results_summary": "The study found a marginally significant association between prenatal arsenic exposure and atopic dermatitis (AD), but DHA supplementation during pregnancy modified this effect, reducing the risk of AD. The results suggest that omega-3 fatty acid supplementation could mitigate the adverse effects of arsenic exposure on AD risk.", "population_specificity": "300 healthy mother-child pairs in Morelos, Mexico (146 placebo, 154 supplement group).", "effective_dosage": "Not specified", "study_duration": "Duration of pregnancy (exact length not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:58.077651+00:00"}
{"study_id": 186869, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the daily DHA intake during pregnancy most likely to achieve maternal-newborn DHA equilibrium (EQ) to optimize newborn DHA status throughout infancy.", "results_summary": "The study sought to identify the optimal DHA intake for pregnant women to reach maternal-newborn DHA equilibrium, but the abstract does not provide specific findings on the achieved outcomes.", "population_specificity": "Pregnant women and their newborns.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:00.131691+00:00"}
{"study_id": 186870, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine if DHA supplementation during pregnancy affects maternal heart rate and heart rate variability metrics.", "results_summary": "Women receiving 800 mg/d DHA had lower heart rate, lower sympathetic index, higher vagally mediated HRV indices, and greater HRV complexity compared to those receiving 200 mg/d. These effects remained significant after adjusting for time, maternal weight, and dietary DHA intake.", "population_specificity": "Pregnant women (\u226518 y old, English speaking, carrying a singleton pregnancy, 12-20 wk of gestation).", "effective_dosage": "200 mg/d or 800 mg/d.", "study_duration": "From 12-20 weeks of gestation until delivery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:01.142470+00:00"}
{"study_id": 186871, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to re-evaluate the adequacy of \u03b1-linolenic acid (\u03b1LNA) conversion into docosahexaenoic acid (DHA) and its nutritional sufficiency.", "results_summary": "The study found that \u03b1LNA conversion to DHA may be nutritionally adequate, as diets excluding EPA and DHA show no adverse health or cognitive effects. Health benefits from dietary EPA and DHA are also observed in vegetarians who rely on \u03b1LNA conversion.", "population_specificity": "General human population, with specific mention of vegetarians.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:01.321269+00:00"}
{"study_id": 186868, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of 4 g/day EPA and DHA supplementation on serum blood lipids, particularly small, dense LDL-C particle concentration, in hyperlipidemic patients on stable statin therapy.", "results_summary": "The study found that n-3 FA supplementation significantly reduced small dense LDL-C (LDL III), non-HDL-C, TG, VLDL-C, and TC compared to placebo, but did not significantly affect LDL-C, HDL-C, or larger LDL subclasses (LDL I and II).", "population_specificity": "Hyperlipidemic patients on stable statin therapy with non-HDL-C >130 mg/dL.", "effective_dosage": "4 g/day (3000 mg EPA + 1000 mg DHA in ethyl ester form).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:01.559913+00:00"}
{"study_id": 186872, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 35, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of n-3 fatty acid supplementation on disease activity indicators and NSAID use in rheumatoid arthritis (RA) patients.", "results_summary": "The study found that n-3 supplementation had a small, statistically insignificant effect on reducing pain, tender/swollen joint counts, and NSAID intake, with very low/low certainty of evidence. Clinical benefits were deemed limited.", "population_specificity": "Rheumatoid arthritis (RA) patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:03.514372+00:00"}
{"study_id": 186874, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether omega-3 PUFA supplementation, including DHA, enhances weight loss and cognitive function in overweight or obese adults on a weight loss diet.", "results_summary": "Omega-3 supplementation significantly reduced abdominal fat mass and percentage compared to the control group, but cognitive improvements (MoCA scores) were similar in both groups without statistical significance.", "population_specificity": "Overweight or obese adults (BMI 27.0\u201335.0 kg/m\u00b2) aged 30\u201360 years.", "effective_dosage": "1020 mg omega-3 PUFAs daily (390 mg DHA, 580 mg EPA, 50 mg other omega-3s).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:05.251260+00:00"}
{"study_id": 186875, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to explore the relationship between n-3 PUFAs (including docosahexaenoic acid) and gut microbiota, and their potential effects on metabolic and immune health.", "results_summary": "The study found that n-3 PUFAs, including DHA, can alter gut microbiota diversity and abundance, potentially improving metabolic health and reducing inflammation. An imbalance in n-3/n-6 PUFA ratios may lead to gut dysbiosis, contributing to obesity and metabolic disorders.", "population_specificity": "General mammalian gut microbiota (not human-specific).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:06.168936+00:00"}
{"study_id": 186876, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if the efficacy of B-vitamin supplementation in slowing cognitive decline was influenced by baseline plasma levels of docosahexaenoic acid (DHA).", "results_summary": "The study found that B-vitamin supplementation had a larger treatment effect on global cognition in participants with higher baseline DHA levels, but no significant interaction was observed for combined omega-3 fatty acids or EPA. Domain-specific cognitive functioning did not show a link to DHA or EPA levels.", "population_specificity": "191 adults aged 65 years or older with baseline plasma total homocysteine \u2265 12 \u03bcmol/L.", "effective_dosage": "400 \u00b5g folic acid and 500 \u00b5g vitamin B12 daily.", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:08.681778+00:00"}
{"study_id": 186880, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential role of omega-3 fatty acids, including Docosahexaenoic Acid, in managing T2DM by influencing gut microbiota and related molecular mechanisms.", "results_summary": "The study suggests that omega-3 fatty acids may positively modulate gut microbiota, potentially improving T2DM management and related complications, though further mechanistic and clinical studies are needed.", "population_specificity": "Individuals with Type-2 diabetes mellitus (T2DM) or related comorbidities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:09.586851+00:00"}
{"study_id": 186878, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 85, "study_goal": "To determine if maternal supplementation with high-dose DHA improves neurodevelopmental outcomes in breastfed, very preterm neonates at 18 to 22 months' corrected age.", "results_summary": "Maternal DHA supplementation did not significantly improve overall neurodevelopmental outcomes, but subgroup analyses suggested a potential benefit for language in neonates born before 27 weeks' gestation. No significant differences were found in cognitive or motor scores between the DHA and placebo groups.", "population_specificity": "Breastfed, preterm neonates born before 29 weeks' gestational age.", "effective_dosage": "High-dose DHA-rich algae oil (specific amount not stated).", "study_duration": "From within 72 hours of delivery until 36 weeks' postmenstrual age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:10.636085+00:00"}
{"study_id": 186877, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of an Omega-3/6 dietary supplement containing Docosahexaenoic Acid (DHA) in ameliorating inattentive symptoms in children with mild ADHD-I.", "results_summary": "The study found no superiority of the Omega-3/6 supplement over placebo in improving inattentive symptoms after 6 months, with similar responder rates between groups. A mild statistical but clinically insignificant improvement was observed in the ADHD-RS-total score, but not in the inattention score.", "population_specificity": "Children aged 6-12 years with inattentive-ADHD and a baseline ADHD-RS-Inattention score \u2265 12.", "effective_dosage": "Two capsules daily, each containing 87 mg DHA (total 174 mg/day).", "study_duration": "6-month double-blind phase followed by a 6-month open-label phase (total 12 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:11.001606+00:00"}
{"study_id": 186879, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether DHA+EPA supplementation could mitigate neuroaxonal injury and inflammation caused by repeated subconcussive head impacts in American football athletes.", "results_summary": "DHA+EPA supplementation increased plasma DHA and EPA levels but did not reduce neurofilament light (NfL) levels or inflammatory cytokines, indicating no significant neuroprotective effect against RSHI. However, participants with the highest plasma DHA+EPA concentrations showed a trend toward lower NfL levels.", "population_specificity": "National Collegiate Athletic Association Division I American football athletes (n = 29, with 12 in the treatment group and 17 in the placebo group).", "effective_dosage": "Not specified in the abstract.", "study_duration": "26 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:11.266533+00:00"}
{"study_id": 186881, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess long-term neurodevelopmental outcomes at preschool age in very preterm infants following neonatal DHA supplementation and evaluate recruitment capacity for follow-up studies.", "results_summary": "The abstract does not report specific results regarding DHA's effects, as it describes a protocol for a future follow-up study rather than completed findings.", "population_specificity": "Very preterm infants (<29 weeks' gestation) and their mothers from five sites in Quebec.", "effective_dosage": "High doses (specific amount not stated in the abstract).", "study_duration": "Until infants reached 36 weeks' postmenstrual age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:13.085449+00:00"}
{"study_id": 186882, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of antenatal omega-3 supplementation (including Docosahexaenoic Acid) on maternal depressive symptoms from pregnancy to 6 months postpartum.", "results_summary": "The study found no significant differences in depressive symptoms (EPDS score) between the omega-3 and placebo groups during pregnancy or postpartum. However, an earlier reduction in depressive symptoms was observed in the omega-3 group, suggesting a potential benefit.", "population_specificity": "Sixty pregnant women with gestational age between 22 and 24 weeks.", "effective_dosage": "Not specified in the abstract.", "study_duration": "From pregnancy (22-24 weeks gestation) to 6 months postpartum.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:14.902499+00:00"}
{"study_id": 186883, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of omega-3 fatty acids, particularly EPA and DHA, in wound regeneration and repair, and to review clinical outcomes of fish skin grafts for chronic, non-healing wounds.", "results_summary": "The study found that acellular fish skin grafts rich in omega-3 fatty acids, including DHA, accelerated wound healing rates and improved outcomes in non-responsive diabetic foot ulcers compared to standard treatments. Omega-3 fatty acids were shown to modulate inflammation, enhance epithelialization, and provide barrier protection against bacteria.", "population_specificity": "Patients with chronic, non-healing wounds such as diabetic foot ulcers and venous leg ulcers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:15.524668+00:00"}
{"study_id": 186884, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of maternal DHA supplementation during lactation on the neonatal growth profile of very preterm infants.", "results_summary": "DHA supplementation positively affected female infants' weight profile and velocity but negatively affected male infants' weight at 36 weeks' postmenstrual age. The effects were statistically significant but varied by sex.", "population_specificity": "Very preterm infants (mean gestational age 26.5 weeks) and their lactating mothers who delivered before 29 weeks' gestation.", "effective_dosage": "1.2 g of DHA daily", "study_duration": "From within 72 hours of delivery up to 36 weeks' postmenstrual age", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:17.866379+00:00"}
{"study_id": 186885, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in alleviating cognitive decline and promoting healthy aging, focusing on their neuroinflammatory resolving effects and bioavailability.", "results_summary": "The study suggests that DHA and EPA are promising for cognitive function and reducing dementia risk in the elderly, though clinical results are inconsistent. Structured forms of these fatty acids show enhanced bioavailability and potential benefits.", "population_specificity": "Elderly individuals (focus on cognitive health and aging).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:18.145560+00:00"}
{"study_id": 186887, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess whether intravenous DHA-containing SMOF-LE was associated with improved bronchopulmonary dysplasia (BPD)-free survival in very preterm infants.", "results_summary": "The study found no significant association between SMOF-LE and BPD-free survival, with similar rates of BPD, severe BPD, and mortality between the SMOF-LE and non-SMOF-LE groups.", "population_specificity": "Very preterm infants born between 23 0/7 and 28 6/7 weeks' gestation in Canadian neonatal intensive care units.", "effective_dosage": "Not specified (administered according to routine care protocols).", "study_duration": "Not specified (neonatal period).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:20.511299+00:00"}
{"study_id": 186886, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether co-supplementation with docosahexaenoic acid (DHA) and vitamin D improves vitamin D status, body composition, and metabolic markers in obese children with vitamin D deficiency.", "results_summary": "Co-supplementation with DHA and vitamin D did not improve vitamin D levels more than vitamin D plus wheat germ oil, but it increased DHA levels, potentially aiding in preventing obesity-related inflammatory complications. Both groups showed reduced fat mass percentage and improved BMI, though all subjects remained obese.", "population_specificity": "Obese children with vitamin D deficiency.", "effective_dosage": "500 mg of DHA and 1200 IU/day of vitamin D3.", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:20.794040+00:00"}
{"study_id": 186889, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the influence of n-3 PUFAs, particularly docosahexaenoic acid (DHA), and their lipid mediators on inflammatory responses in respiratory health, focusing on prevention and potential treatment of respiratory diseases.", "results_summary": "The study found that DHA and its lipid mediators have pro-resolution effects on inflammation, showing beneficial effects in preventing and possibly treating respiratory diseases like asthma, airway allergic syndromes, and chronic obstructive pulmonary disease.", "population_specificity": "Individuals with respiratory diseases (asthma, airway allergic syndromes, chronic obstructive pulmonary disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:22.034234+00:00"}
{"study_id": 186890, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the influence of exercise and DHA/EPA supplementation on lipid profiles during pregnancy.", "results_summary": "The study compared aerobic exercise versus low-intensity stretching/breathing on maternal lipids, DHA, and EPA levels during pregnancy, but specific results regarding DHA's effects were not detailed in the abstract.", "population_specificity": "Pregnant women from 16 weeks gestation until delivery.", "effective_dosage": "Not specified", "study_duration": "From 16 weeks gestation until delivery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:23.755980+00:00"}
{"study_id": 186891, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine whether supplementation with fish oil (containing docosahexaenoic acid) affects CathepsinD levels and its association with metabolic parameters in overweight/obese pregnant women.", "results_summary": "The study found that docosahexaenoic acid supplementation did not modify serum CathepsinD levels. CathepsinD was influenced by body fat and low-grade inflammation, which varied based on gestational diabetes status.", "population_specificity": "Overweight/obese pregnant women (n = 438).", "effective_dosage": "1.9 g docosahexaenoic acid and 0.22 g eicosapentaenoic acid (daily, as part of fish oil supplementation).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:25.235625+00:00"}
{"study_id": 186892, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to compare and rank the effectiveness of nutritional supplementations, including docosahexaenoic acid (DHA), as adjunctive treatments for schizophrenia.", "results_summary": "The study found that omega-3 polyunsaturated fatty acids (including DHA) were less effective than N-acetyl cysteine (NAC) in improving PANSS scores but did not significantly differ from vitamin D or folic acid/vitamin B12.", "population_specificity": "Schizophrenia patients (1165 participants across 17 RCTs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:26.723428+00:00"}
{"study_id": 186893, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to characterize the mammary gland transcriptomes in lactating mothers supplemented with different doses of DHA and assess its impact on inflammation-related gene expression.", "results_summary": "Increased DHA supplementation (1000 mg/d) upregulated genes associated with improved immune regulation and oxidative stress management while downregulating proinflammatory genes, suggesting a modulation of mammary gland inflammation-related gene expression. The study identified 409 differentially expressed genes, including notable changes in NFKBIA and IL18BP (upregulated) and IL7R and IL1RL1 (downregulated).", "population_specificity": "Lactating mothers who delivered preterm (<29 weeks gestation) at the University of Cincinnati Medical Center.", "effective_dosage": "200 mg/d (standard group) and 1000 mg/d (experimental group).", "study_duration": "Supplementation began within 7 days of delivery, with milk samples analyzed 4 weeks post-enrollment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:29.324333+00:00"}
{"study_id": 186895, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the effect of n-3 PUFA (including Docosahexaenoic Acid) on lean mass and muscle protein synthesis in sedentary individuals or those undergoing limb immobilization.", "results_summary": "Five of six studies showed increased skeletal muscle volume and mass with n-3 PUFA supplementation. Two studies reported improved muscle protein fractional synthesis rate, but no significant effects were observed on mTOR, Akt, or gene expression.", "population_specificity": "Sedentary humans or those undergoing limb immobilization.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:29.399994+00:00"}
{"study_id": 186888, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to investigate the cognitive effects of DHA supplementation in older adults with mild cognitive impairment and examine the moderating role of the APOE \u025b4 allele.", "results_summary": "The study found no significant effect of DHA on cognitive measures but observed a positive effect on systolic blood pressure and improvements in depression and anxiety scores among APOE \u025b4 carriers.", "population_specificity": "Older adults (ages 60-90) with mild cognitive impairment from New Zealand.", "effective_dosage": "1491 mg DHA + 351 mg eicosapentaenoic acid per day.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:29.822183+00:00"}
{"study_id": 186896, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of long-chain omega-3 fatty acid supplementation (including Docosahexaenoic Acid) during pregnancy, lactation, and infancy through an umbrella review of systematic reviews and meta-analyses.", "results_summary": "The study found moderate to high certainty evidence that omega-3 supplementation reduced risks of pre-eclampsia, low-birth weight, severe retinopathy of prematurity, and cholestasis, while also showing favorable effects on preterm delivery, depression, glycemic control, inflammation, immune response, and infant development.", "population_specificity": "Pregnant women, lactating mothers, and infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:30.292859+00:00"}
{"study_id": 186897, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the neurodevelopmental outcomes of LCPUFA supplementation, specifically DHA and AA, in prematurely born infants.", "results_summary": "The review found that feed containing 0.3% DHA and 0.6% AA was associated with more positive neurodevelopmental outcomes compared to LCPUFA-deplete feed, though evidence was weakened by heterogeneity. The study also discussed broader physiological effects and maternal LCPUFA status as a modifiable factor.", "population_specificity": "Prematurely born infants.", "effective_dosage": "0.3% DHA and 0.6% AA in feed.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:31.719465+00:00"}
{"study_id": 186899, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of krill oil (KO) versus fish oil (FO) on the enrichment of n-3 PUFA, including docosahexaenoic acid (DHA), in plasma phospholipids in young women after 30 days of supplementation.", "results_summary": "Supplementation with both KO and FO increased n-3 PUFA levels in plasma phospholipids, but KO resulted in significantly greater concentrations of 35 out of 70 molecular species containing EPA, DHA, and DPAn-3 compared to FO, particularly in ether-phospholipids.", "population_specificity": "Healthy women aged 18-45 years.", "effective_dosage": "KO group: 7 capsules/day (1.27 g n-3 PUFA total); FO group: 5 capsules/day (1.44 g n-3 PUFA total).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:34.556089+00:00"}
{"study_id": 186900, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of 1000 mg/day versus 200 mg/day of DHA on maternal inflammation, a potential mechanism for preventing preterm birth.", "results_summary": "Higher-dose DHA (1000 mg/day) was superior to 200 mg/day in preventing preterm birth, with immunomodulatory effects linked to changes in sRAGE and IL-6 levels, suggesting a mechanistic explanation for its efficacy.", "population_specificity": "Pregnant women at 12-20 weeks' gestation.", "effective_dosage": "1000 mg/day and 200 mg/day.", "study_duration": "From enrollment (12-20 weeks' gestation) until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:35.329305+00:00"}
{"study_id": 186903, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop equations for converting n-3 fatty acid measurements between different blood fractions and to establish cut-points for defining low and replete n-3 status in pregnant women.", "results_summary": "The study found strong relationships between n-3 fatty acid status in whole blood and plasma, enabling interconversion equations. It also derived cut-points for defining n-3 status in plasma and RBC based on established whole blood standards.", "population_specificity": "457 pregnant women in a multicentre randomised controlled trial.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:38.430417+00:00"}
{"study_id": 186901, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to test whether omega-3 supplementation, including docosahexaenoic acid, could prevent late-life depression and improve mood scores in the general adult population.", "results_summary": "The study found that omega-3 supplementation led to a small but statistically significant increase in depression risk compared to placebo, with no significant difference in mood scores. Adverse event rates were similar between omega-3 and placebo groups.", "population_specificity": "Adults aged 50 years or older without clinically relevant depressive symptoms at baseline, including those at risk of incident or recurrent depression.", "effective_dosage": "1 g/d of fish oil (containing 465 mg eicosapentaenoic acid and 375 mg docosahexaenoic acid).", "study_duration": "Median treatment duration of 5.3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:38.648309+00:00"}
{"study_id": 186904, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the relationship between Docosahexaenoic Acid (DHA) and Alzheimer's Disease, focusing on its potential role in prevention or treatment and the complexities of brain uptake.", "results_summary": "The study found inconsistent benefits of DHA supplementation for Alzheimer's Disease, with variable DHA status in autopsy studies. It highlighted the complexity of DHA's metabolic fate and the potential role of adipose tissue as a DHA depot for the brain.", "population_specificity": "Not specified (general discussion of Alzheimer's Disease and DHA research).", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:38.763506+00:00"}
{"study_id": 186905, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate the relationship between essential fatty acid deficiencies and CFTR function in animal models of Cystic Fibrosis, including potential implications for Docosahexaenoic Acid.", "results_summary": "The study found that essential fatty acid status in CF animal models depends on genotype and phenotype, with a bidirectional relationship between CFTR and essential fatty acids proposed. Future research should identify optimal animal models for therapeutic development.", "population_specificity": "Animal models (mice, rats, sheep, pigs, ferrets) with CFTR mutations mimicking Cystic Fibrosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:39.023023+00:00"}
{"study_id": 186902, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of daily intake of a novel combination of essential fatty acids, including docosahexaenoic acid, on signs and symptoms of dry eye disease (DED).", "results_summary": "Supplementation with docosahexaenoic acid, combined with other fatty acids, significantly improved symptoms in extremely symptomatic DED participants (OSDI \u226552), with no significant changes in ocular assessments. The treatment group showed a 34% increase in Omega-3 Index, while the placebo group showed no change.", "population_specificity": "Participants with moderate to severe dry eye disease (baseline OSDI score 52.2 \u00b1 16.5).", "effective_dosage": "300 mg docosahexaenoic acid daily (combined with 1200 mg eicosapentaenoic acid and 150 mg \u03b3-linoleic acid).", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:39.935928+00:00"}
{"study_id": 186906, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of docosahexaenoic acid (DHA) and other omega-3-derived mediators in coronary microvascular dysfunction (CMD) in women with ischemia and no obstructive coronary disease.", "results_summary": "The study found that women with CMD had significantly higher plasma levels of docosahexaenoic acid compared to reference subjects, suggesting a potential imbalance in specialized proresolving mediators. However, the abstract does not clarify whether elevated DHA levels were beneficial or detrimental in this context.", "population_specificity": "31 women with confirmed CMD enrolled in the WARRIOR trial, compared to 12 gender and age-matched reference subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:40.927355+00:00"}
{"study_id": 186908, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the impact of short-term shark liver oil (SLO) supplementation on biochemical parameters and erythrocyte fatty acid composition, including docosahexaenoic acid (DHA), in young healthy women.", "results_summary": "SLO supplementation significantly increased DHA content in erythrocytes, improved the omega-3 index, and reduced C-reactive protein levels and intracellular cholesterol. It also altered membrane fluidity by decreasing the saturated-to-unsaturated fatty acid ratio.", "population_specificity": "Young healthy women", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:44.873817+00:00"}
{"study_id": 186911, "supplement_id": 1089, "safety_score": "80", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to determine whether prenatal DHA supplementation improves childhood behavior and executive function, as assessed by standardized parental report scales.", "results_summary": "Prenatal DHA supplementation showed no advantage to childhood behavior and instead appeared to have adverse effects, with worse scores on multiple behavioral and executive function assessments compared to placebo.", "population_specificity": "Women with singleton pregnancies <21 weeks' gestation and their children followed up to age seven.", "effective_dosage": "800 mg DHA/day", "study_duration": "From trial entry (<21 weeks' gestation) until birth", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:46.801659+00:00"}
{"study_id": 186914, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if maternal FADS2 gene variants influence the effect of prenatal DHA supplementation on offspring neurodevelopment at 5 years.", "results_summary": "Prenatal DHA supplementation improved cognitive and memory scores in children of mothers with the TT genotype for FADS2 SNP rs174602, but not in other genotypes. No significant effects were observed for SNP rs174575.", "population_specificity": "Pregnant women (gestation week 18-22) and their offspring at 5 years.", "effective_dosage": "400 mg/day of preformed algal DHA", "study_duration": "From gestation week 18-22 through delivery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:48.621643+00:00"}
{"study_id": 186909, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combined EPA+DPA+DHA supplementation could attenuate serum Nf-L elevations and improve cardiovascular and neuroprotective markers in American-style football athletes.", "results_summary": "The study found that w-3 FA supplementation significantly increased plasma EPA and DHA levels, improved the omega-3 index, and attenuated elevations in Nf-L, suggesting cardio- and neuroprotective effects. The control group showed significant increases in Nf-L, while the treatment group did not.", "population_specificity": "American-style football athletes", "effective_dosage": "2000mg DHA, 560mg EPA, 320mg DPA daily", "study_duration": "Pre-season and throughout the regular season", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:48.751596+00:00"}
{"study_id": 186912, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to review recent studies on the effects of PUFA supplementation, including docosahexaenoic acid (DHA), in heart failure (HF) patients, focusing on anti-inflammatory, antioxidant, and cardioprotective mechanisms.", "results_summary": "DHA and EPA demonstrated anti-inflammatory and antioxidant properties, inhibited cardiac fibrosis, improved cardiac function (e.g., increased LVEF, reduced BNP and sNE levels), and reduced HF risk post-MI. The effects were dose- and duration-dependent, with 1-2 g daily showing positive outcomes.", "population_specificity": "Heart failure (HF) patients, including post-myocardial infarction (MI) cases.", "effective_dosage": "1-2 g daily", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:48.972021+00:00"}
{"study_id": 186913, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of maternal DHA supplementation on maternal-infant DHA equilibrium status and fetal neurodevelopment.", "results_summary": "Higher maternal DHA supplementation (800 mg/day) increased the likelihood of achieving maternal-infant DHA equilibrium, but equilibrium status did not affect fetal neurodevelopment. No maternal-infant dyads with maternal RBC-DHA \u2264 6.96% achieved equilibrium.", "population_specificity": "Pregnant women between 12 and 20 weeks gestation and their infants.", "effective_dosage": "200 mg/day or 800 mg/day until delivery.", "study_duration": "From enrollment (12-20 weeks gestation) until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:49.599053+00:00"}
{"study_id": 186915, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine if omega-3 fatty acids (DHA + EPA) could alleviate inflammatory responses and clinical symptoms in hospitalized Covid-19 patients when used as an adjunct therapy.", "results_summary": "Omega-3 supplementation improved clinical symptoms (body pain, fatigue, appetite) and reduced inflammatory markers (CRP, ESR) but had no effect on olfactory symptoms or liver enzymes.", "population_specificity": "30 adult men and women diagnosed with Covid-19 in Tehran.", "effective_dosage": "2 grams of DHA + EPA daily.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:50.396207+00:00"}
{"study_id": 186907, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of n-3 LCPUFA supplementation, including docosahexaenoic acid (DHA), on self-regulation and executive functioning in typically developing preschool-aged children.", "results_summary": "The study found that supplementation with 1.6 g of EPA and DHA per day for 12 weeks may enhance self-regulation and executive functioning in preschool-aged children, though specific results are not detailed in the abstract.", "population_specificity": "Typically developing preschool-aged children.", "effective_dosage": "1.6 g of EPA and DHA per day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:52.965199+00:00"}
{"study_id": 186917, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the cardiovascular benefits and safety of docosahexaenoic acid (DHA) in patients with or at risk of atherosclerotic cardiovascular disease (ASCVD).", "results_summary": "Low-dose DHA (1 g daily or less) did not reduce cardiovascular events or death, while higher doses (4 g daily) showed mixed results\u2014icosapent ethyl (EPA) demonstrated benefits, but DHA combined with EPA did not. Adverse effects included gastrointestinal disorders, bleeding, and a possible increased risk of atrial fibrillation.", "population_specificity": "Patients with established ASCVD or at risk of ASCVD (including those with diabetes and multiple cardiovascular risk factors).", "effective_dosage": "1 g daily or less (low-dose), 4 g daily (high-dose).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:54.778800+00:00"}
{"study_id": 186918, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether DHA-rich n-3 PUFA supplementation, alone or combined with resistance training, improves muscle function, body composition, and cardiovascular health markers in overweight/obese postmenopausal women.", "results_summary": "DHA-rich supplementation lowered diastolic blood pressure and circulating triglycerides while increasing muscle quality in lower limbs, but no synergistic effects were observed when combined with resistance training.", "population_specificity": "Overweight/obese postmenopausal women aged 55-70 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:55.404040+00:00"}
{"study_id": 186919, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of docosahexaenoic acid (DHA) to reduce side effects of chemotherapy and block cancer cell proliferation in hematological neoplasias.", "results_summary": "The study found that DHA, along with EPA, helps mitigate chemotherapy side effects and inhibits cancer cell metabolic pathways, improving patient quality of life when used alongside traditional or innovative therapies like monoclonal antibodies or CAR-T therapy.", "population_specificity": "Patients with hematological neoplasias (cancer types affecting blood, bone marrow, or lymph nodes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:57.576334+00:00"}
{"study_id": 186920, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effect of omega-3 supplementation, including Docosahexaenoic Acid, on seizure frequency in adults and children with epilepsy.", "results_summary": "The meta-analysis found that omega-3 supplementation significantly reduced seizure frequency, with a weighted mean difference of -6.15 (95% CI: -7.78, -4.53). The results suggest beneficial effects in both adult and pediatric populations.", "population_specificity": "Adults and children with epilepsy.", "effective_dosage": "1000-2880 mg/day.", "study_duration": "12 to 42 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:58.003367+00:00"}
{"study_id": 186921, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of omega-3 PUFA (including Docosahexaenoic Acid) supplementation on schizophrenia symptoms across different disease phases (prodromal, first-episode, and chronic).", "results_summary": "Omega-3 supplementation improved positive and negative symptoms in the prodromal phase, mainly negative symptoms in first-episode patients, and had partial effects in chronic schizophrenia. Efficacy was influenced by factors like age, illness duration, baseline omega-3 levels, and antioxidant capacity.", "population_specificity": "Patients with schizophrenia at different developmental phases (prodromal, first-episode, chronic).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:58.184550+00:00"}
{"study_id": 186923, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) have differential effects on metabolic syndrome (MetS) risk factors in humans.", "results_summary": "DHA increased serum levels of total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), and high-density lipoprotein-cholesterol (HDL-C), while also raising insulin levels, particularly in younger individuals (<60 years) and short-term supplementation (<3 months). Both EPA and DHA effectively lowered triglycerides (TG).", "population_specificity": "Individuals with or at risk of metabolic syndrome (MetS).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Varied, with some subgroups analyzed for durations <3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:42:59.971291+00:00"}
{"study_id": 186922, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential synergistic effects of combining aspirin (ASA) and docosahexaenoic acid (DHA) in preventing cardiovascular disease (CVD) and colorectal adenomas.", "results_summary": "DHA was found to be effective in reducing blood pressure and modulating systemic inflammation, with synergistic effects observed when combined with aspirin. The study noted that EPA-to-DHA ratio is important for efficacy, though high-dose EPA was more effective in lowering CVD events in high-risk individuals.", "population_specificity": "Patients with cardiovascular disease, ASA-resistant or diabetic patients, and those with EPA- and DHA-deficiency.", "effective_dosage": "Not specified for DHA alone; low-dose ASA (75-100 mg/d) and ultra-low dose (30 mg/d) were mentioned for CVD prevention.", "study_duration": "Not specified.", "interactions": "Synergistic effects with aspirin (ASA) were noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:00.777945+00:00"}
{"study_id": 186924, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of fish oil (containing docosahexaenoic acid) on emotion-generated corticolimbic functional connectivity in depressed youth at high risk for bipolar I disorder.", "results_summary": "Fish oil supplementation significantly increased erythrocyte EPA+DHA levels and altered functional connectivity in key brain regions, correlating with reduced symptom severity in depressed high-risk youth. The placebo group showed no such improvements.", "population_specificity": "Antidepressant-free youth with a current depressive disorder diagnosis and a biological parent with bipolar I disorder.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:01.703992+00:00"}
{"study_id": 186926, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the cardiovascular benefits of omega-3 fatty acids, specifically docosahexaenoic acid (DHA), and compare its efficacy with eicosapentaenoic acid (EPA) in reducing atherosclerotic cardiovascular disease risk.", "results_summary": "The study found inconsistent data regarding the benefit of combining DHA and EPA in cardiovascular disease patients, while EPA (specifically icosapent ethyl) demonstrated clear atherosclerotic risk reduction in statin-treated patients. DHA's standalone efficacy was not conclusively supported.", "population_specificity": "Patients with cardiovascular disease, particularly those on statin therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:03.965351+00:00"}
{"study_id": 186927, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of docosahexaenoic acid (DHA) in preventing atherosclerotic cardiovascular disease (ASCVD) by examining its anti-inflammatory and triglyceride-lowering effects.", "results_summary": "The study found that omega-3 PUFAs, including DHA, reduce ASCVD risk by lowering hypertriglyceridemia and ameliorating inflammation, with meta-analyses and recent clinical trials supporting these protective effects. However, earlier large randomized trials showed inconsistent results.", "population_specificity": "General population with a focus on ASCVD risk.", "effective_dosage": "High dose of eicosapentaenoic acid (specific dosage not mentioned for DHA).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:04.898620+00:00"}
{"study_id": 186929, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to examine the effect and optimal dosage of n-3 PUFA supplementation on muscle hypertrophy, muscle strength, and DOMS when combined with physical exercise.", "results_summary": "The study found that n-3 PUFA does not improve muscle hypertrophy, muscle strength, or skeletal muscle biomarkers beyond training benefits but improves DOMS recovery and muscle function (measured by ROM, EMD, and muscle quality).", "population_specificity": "Healthy humans", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:05.587113+00:00"}
{"study_id": 186928, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether fish oil supplementation (containing DHA and EPA) could modify emotion-related brain network abnormalities in depressed adolescent bipolar offspring.", "results_summary": "Fish oil supplementation increased erythrocyte EPA+DHA levels and improved network clustering, efficiency, and node centralities in brain regions associated with emotion processing, compared to placebo. Patients initially showed lower EPA+DHA levels and impaired network organization relative to healthy controls.", "population_specificity": "Medication-free depressed adolescent bipolar offspring (n=53 patients, n=53 healthy controls).", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:07.201696+00:00"}
{"study_id": 186930, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of omega-3 fatty acids, particularly Docosahexaenoic Acid (DHA), in managing psychiatric disorders and improving brain function.", "results_summary": "The study found that omega-3 fatty acids, including DHA, improve brain functioning and neuronal activity, and are effective in treating depressive symptoms with minimal side effects compared to antidepressants. The combination of EPA and DHA was noted to be particularly efficacious.", "population_specificity": "Depressive patients and general human health (including pregnant women).", "effective_dosage": "1g/d to 10g/d.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:07.254719+00:00"}
{"study_id": 186931, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementation with DHA-rich or EPA-rich oils improves cognition, prefrontal cortex hemoglobin oxygenation, and memory consolidation in healthy adults.", "results_summary": "EPA-rich oil improved global cognitive function and memory accuracy compared to placebo and DHA-rich oil, while both EPA and DHA showed trends toward reduced prefrontal cortex oxygenated hemoglobin, suggesting potential neural efficiency benefits.", "population_specificity": "Healthy adults aged 25-49 years (n = 310).", "effective_dosage": "900 mg DHA/day + 270 mg EPA/day (DHA-rich oil) or 360 mg DHA/day + 900 mg EPA/day (EPA-rich oil).", "study_duration": "26 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:09.625647+00:00"}
{"study_id": 186934, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to propose updating Dietary Reference Intakes (DRIs) for docosahexaenoic acid (DHA) and other nutrients based on current evidence and biomarker levels.", "results_summary": "The abstract suggests that current DRIs for nutrients like DHA need updating to reflect modern evidence and biomarker-based recommendations, but it does not report specific findings on DHA's effects.", "population_specificity": "Healthy individuals in various life stages and gender groups (general population).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:10.165105+00:00"}
{"study_id": 186935, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of DHA-rich fish oil supplementation on circulating oxylipin profiles and inflammation markers in obese females.", "results_summary": "The abstract does not provide specific results regarding DHA's effects, as it describes the study design and rationale rather than outcomes.", "population_specificity": "Pre-menopausal females aged 20-55 with a BMI \u226530.", "effective_dosage": "4 g DHA + 0.8 g EPA per day.", "study_duration": "4-week supplementation phases with a 4-week washout.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:12.211067+00:00"}
{"study_id": 186936, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the mechanisms by which marine n-3 fatty acids, including Docosahexaenoic Acid, modify neutrophil function and summarize clinical trial evidence from the past 15 years on their effects.", "results_summary": "The study found that marine n-3 fatty acids alter neutrophil function by changing the phospholipid bilayer composition, blocking transcription factors, reducing pro-inflammatory gene expression, and disrupting lipid rafts. Clinical trial evidence suggests these modifications can influence neutrophil activity in disease-specific ways without compromising immune function.", "population_specificity": "Vulnerable, aging populations with inflammatory conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:14.664635+00:00"}
{"study_id": 186932, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of EPA and DHA supplementation on leptin, adiponectin, and the leptin-to-adiponectin ratio (LAR) in older adults with obesity and inflammatory conditions.", "results_summary": "The study found a 23% reduction in LAR between weeks 4 and 8 in the EPA+DHA group, though no significant between-group differences were detected. Adiponectin levels were negatively associated with IL-1\u03b2 at week 4 and TNF-\u03b1 at week 8.", "population_specificity": "Older adults (mean age 61.3) with obesity and inflammatory conditions.", "effective_dosage": "1.5 g EPA + 1.0 g DHA daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:14.947187+00:00"}
{"study_id": 186939, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether DHA supplementation improves behavior, emotional functioning, and general health in infants born <29 weeks' gestation.", "results_summary": "The study protocol describes a follow-up of infants from a randomized controlled trial, hypothesizing that DHA supplementation will benefit parent-rated behavior and emotional status, with a target effect size of 0.25 SD. Results are pending dissemination.", "population_specificity": "Infants born <29 weeks' gestation in Australian sites.", "effective_dosage": "60 mg/kg/day of DHA.", "study_duration": "Until 36 weeks' postmenstrual age or discharge home, whichever occurred first.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:16.475442+00:00"}
{"study_id": 186938, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to investigate the interaction between aspirin use and RBC EPA+DHA levels (including docosahexaenoic acid) on cardiovascular disease outcomes.", "results_summary": "The study found that RBC EPA+DHA levels interacted with aspirin use, showing reduced CVD risk in non-aspirin users but increased risk in aspirin users within specific quintiles. Similar patterns were observed for EPA and DHA alone but not for DPA and AA.", "population_specificity": "2500 participants without known CVD from the Framingham Heart Study.", "effective_dosage": "Not specified (measured as % of total fatty acids in RBCs).", "study_duration": "Median follow-up of 7.2 years.", "interactions": "Significant interaction with aspirin use noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:16.947957+00:00"}
{"study_id": 186941, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare Polish and international recommendations regarding dietary supplementation during pregnancy, including the role of Docosahexaenoic Acid (DHA).", "results_summary": "The study found that Polish guidelines recommend at least 600 mg of DHA daily for pregnant women, increasing to 1000 mg daily for those at high risk of premature birth. The abstract does not report specific outcomes related to DHA's effects but highlights its inclusion in supplementation guidelines.", "population_specificity": "Pregnant women, particularly those at high risk of premature birth.", "effective_dosage": "At least 600 mg daily (1000 mg for high-risk pregnancies).", "study_duration": "Entire pregnancy period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:19.188777+00:00"}
{"study_id": 186940, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of high-dose supplemental n-3 PUFAs (EPA + DHA) on circulating lipoprotein subfractions, standard lipids, apolipoproteins, fatty acids, and glycemic control in individuals with abdominal obesity.", "results_summary": "High-dose EPA + DHA supplementation significantly reduced VLDL subfractions and TAGs while increasing LDL and HDL subfractions, indicating favorable changes in lipoprotein profiles associated with reduced cardiometabolic risk.", "population_specificity": "Females (n=16) and males (n=23) with abdominal obesity.", "effective_dosage": "Females: 3 g/d EPA + DHA; Males: 4 g/d EPA + DHA.", "study_duration": "Two 7-week intervention periods separated by a 9-week washout.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:20.561884+00:00"}
{"study_id": 186942, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether docosahexaenoic acid (DHA) reduces vascular inflammation and whether EPA is superior to DHA in this regard.", "results_summary": "The study found that EPA was more effective than DHA in reducing markers of acute and chronic vascular inflammation, with DHA showing less pronounced effects. EPA significantly reduced CCL2 and VCAM1 expression, while DHA's impact was not as statistically significant.", "population_specificity": "40 healthy volunteers and preclinical models (C57Bl/6J mice and ApoE-deficient mice).", "effective_dosage": "4 g daily for human volunteers; 600 mg/kg/day for preclinical models.", "study_duration": "30 days for human volunteers.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:21.553624+00:00"}
{"study_id": 186943, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of n-3 PUFAs, including Docosahexaenoic Acid, on depressive symptoms in individuals with or without diagnosed depression.", "results_summary": "The meta-analysis of 20 studies found that n-3 PUFA supplementation significantly reduced depressive symptoms compared to placebo, with a standardized mean difference of -0.34 (95% CI: -0.55, -0.12). The results suggest a modest but statistically significant benefit.", "population_specificity": "Individuals with or without diagnosed depression (7,682 participants across 25 studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:24.117938+00:00"}
{"study_id": 186944, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether folic acid and DHA, alone or in combination, improve cognitive function and reduce blood amyloid-\u03b2 levels in patients with mild cognitive impairment (MCI).", "results_summary": "DHA improved cognitive function (FSIQ, information, arithmetic, and digit span scores) and reduced A\u03b240 levels. The combination of folic acid and DHA showed additional benefits in reducing A\u03b242 and A\u03b240 levels compared to DHA alone, though cognitive improvements declined by 12 months.", "population_specificity": "160 MCI patients aged over 60 years in Tianjin, China (138 completed the trial).", "effective_dosage": "800 mg/day of DHA.", "study_duration": "6 months (cognitive function also measured at 12 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:24.796625+00:00"}
{"study_id": 186945, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 70, "study_goal": "The researchers aimed to assess the omega-3 fatty acid status of pregnant women in the UK and determine its association with recurrent spontaneous early preterm birth.", "results_summary": "The study found that most participants had low EPA+DHA levels, but there was no association between omega-3 status and recurrent early preterm birth. The odds ratio for recurrence was not statistically significant (0.91, 95% CI 0.38-2.15).", "population_specificity": "High-risk pregnant women in the UK with previous early preterm birth (n=283) and a control group with previous term births (n=96).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:26.033099+00:00"}
{"study_id": 186948, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the biological effects of fish oil supplementation, particularly focusing on its use in patients with various diseases and immune statuses.", "results_summary": "The abstract does not provide specific findings regarding Docosahexaenoic Acid's effects, only mentioning its common use in human nutrition and treatment settings.", "population_specificity": "Patients with a variety of diseases and immune statuses.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:26.663109+00:00"}
{"study_id": 186946, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to determine whether long-term administration of docosahexaenoic acid (DHA) combined with eicosapentaenoic acid (EPA) reduces the risk of incident atrial fibrillation (AF) in adults aged 50 or older.", "results_summary": "The study found no significant difference in the risk of incident AF between participants taking EPA-DHA and those taking placebo, with hazard ratios indicating no meaningful effect. The findings do not support the use of EPA-DHA for primary prevention of AF.", "population_specificity": "Adults aged 50 years or older without prior cardiovascular disease, cancer, or AF, recruited from all 50 US states.", "effective_dosage": "460 mg/d of EPA and 380 mg/d of DHA.", "study_duration": "Median follow-up of 5.3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:26.921004+00:00"}
{"study_id": 186950, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a 4-week supplementation of EPA and DHA could reduce muscle damage caused by eccentric contractions in untrained men.", "results_summary": "The study found that EPA and DHA supplementation improved joint flexibility immediately after exercise and reduced muscle fiber damage (as indicated by lower serum CK levels 3 days post-exercise), but did not significantly affect other measured outcomes like muscle soreness or strength.", "population_specificity": "Untrained men", "effective_dosage": "600 mg EPA and 260 mg DHA per day", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:30.183511+00:00"}
{"study_id": 186949, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether 400 mg/day of algal DHA supplementation during pregnancy improves newborn anthropometry (birth weight, length, head circumference) and gestational age in women from low- and middle-income countries.", "results_summary": "The study tested the effectiveness of 400 mg/day algal DHA versus placebo in pregnant women but did not report specific outcome results in the provided abstract. The primary focus was on newborn anthropometry and secondary outcomes like gestational age and APGAR scores.", "population_specificity": "Pregnant women (singleton gestation, 14-20 weeks' gestation at enrollment) in India.", "effective_dosage": "400 mg/day (200 mg \u00d7 2 microencapsulated algal DHA tablets).", "study_duration": "From enrollment (\u226420 weeks' gestation) through delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:30.926480+00:00"}
{"study_id": 186951, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the bioavailability and fetal accretion of DHA when supplemented in phospholipid (PL) or triglyceride (TG) forms during pregnancy.", "results_summary": "The study found no consistent differences in fetal DHA accretion between PL and TG forms, though other lipid species like lyso-phospholipids showed promising bioavailability improvements. Results varied by animal model, physiological status, and fat sources.", "population_specificity": "Pregnant individuals (primarily animal models referenced).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:31.807862+00:00"}
{"study_id": 186952, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 85, "study_goal": "The researchers aimed to determine if enteral DHA supplementation in infants born <29 weeks' gestation improves cognitive development at 5 years of age corrected for prematurity.", "results_summary": "The study found that DHA supplementation did not reduce the risk of bronchopulmonary dysplasia (BPD) and may have increased the risk. Cognitive outcomes at 5 years are pending assessment.", "population_specificity": "Infants born <29 weeks' gestation.", "effective_dosage": "60 mg/kg/day.", "study_duration": "First months of life (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:33.241184+00:00"}
{"study_id": 186954, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of DHA supplementation during the first 1000 days of life on childhood behavioral functioning.", "results_summary": "The study found limited evidence of DHA's effect on behavioral development, with most comparisons showing null effects, no positive effects, and 23 instances where the DHA group performed worse than controls. Two large trials detected adverse effects.", "population_specificity": "Women and infants during the first 1000 days of life, with follow-up assessments in childhood.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:35.158149+00:00"}
{"study_id": 186937, "supplement_id": 1089, "safety_score": "80", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dietary counselling and a fish oil-enriched oral nutritional supplement (containing DHA and EPA) could reduce weight loss and improve outcomes in cancer patients undergoing radiotherapy to the gastrointestinal area.", "results_summary": "The study found no significant effect of the intervention on weight loss, quality of life, or radiotherapy-related side effects compared to standard care. However, post hoc analysis suggested a dose-response relationship, with higher compliance to the fish oil supplement correlating with reduced weight loss during radiotherapy.", "population_specificity": "Outpatients with cancer commencing radiotherapy to the gastrointestinal or pelvic area.", "effective_dosage": "1.1 g DHA and 2.2 g EPA daily (as part of a 33.8 g protein oral nutritional supplement).", "study_duration": "5-7 weeks during radiotherapy, with follow-up at 12 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:35.872194+00:00"}
{"study_id": 186953, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the roles of omega-3 PUFAs, including Docosahexaenoic Acid, in treating hypertriglyceridemia and preventing cardiovascular events.", "results_summary": "The study found that marine-derived omega-3 PUFAs reduce triglycerides and have pleiotropic effects like decreasing inflammation and improving plaque stability, though clinical trial data on cardiovascular outcomes were inconsistent. Recent data suggest prescription eicosapentaenoic acid ethyl ester may reduce atherosclerotic cardiovascular disease events in selected populations.", "population_specificity": "Patients without clinical atherosclerotic cardiovascular disease.", "effective_dosage": "2 or more servings of fatty fish per week or dietary supplementation if fish intake is inadequate (specific dosage not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:35.967845+00:00"}
{"study_id": 186955, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the effects of omega-3 PUFAs, including Docosahexaenoic Acid (DHA), on gut microbiota, intestinal immunity, inflammation, and their role in maintaining gut immunity-microbiota balance.", "results_summary": "The study found that omega-3 PUFAs, including DHA, influence gut microbiota, intestinal immune tolerance, and inflammation, and play a role in maintaining gut immunity-microbiota balance. Omega-3 supplementation may help prevent and alleviate intestinal diseases by targeting specific pathways.", "population_specificity": "Not specified (general human health focus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:36.082570+00:00"}
{"study_id": 186956, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to summarize findings from randomized, controlled trials on the effects of EPA+DHA supplementation on circulating levels of leptin and adiponectin to assess its potential role in reducing systemic inflammation.", "results_summary": "Eighteen studies reported lower leptin and/or higher adiponectin levels with EPA+DHA supplementation, with 9 showing statistically significant differences. However, results varied due to differences in doses, duration, and population characteristics.", "population_specificity": "Studies were conducted in 16 countries, but specific population details are not provided.", "effective_dosage": "0.52 to 4.2 g/day", "study_duration": "4 to 24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:39.370906+00:00"}
{"study_id": 186957, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the bioavailability, transport mechanisms, and role of DHA in preventing neurodegenerative disorders, as well as explore novel therapeutic forms like DHA-lysoPC.", "results_summary": "The study found that DHA is critical for brain function and cognitive health, with the esterified form (DHA-lysoPC) being more effectively incorporated into the brain than triacylglycerol forms. It also highlighted the role of specific transport mechanisms (APOE4 and Mfsd2a) in DHA delivery to the brain.", "population_specificity": "Not specified (general review of studies on DHA and neurodegenerative disorders).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:40.294512+00:00"}
{"study_id": 186958, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to examine the evidence for long-chain omega-3 polyunsaturated fatty acids (LC n-3 PUFA), including docosahexaenoic acid, in reducing delayed onset muscle soreness (DOMS) and inflammation following eccentric exercise.", "results_summary": "LC n-3 PUFA supplementation showed favorable effects on eccentric exercise-induced DOMS and inflammatory markers, but study design limitations and variability in protocols hindered definitive conclusions on optimal dosage and duration.", "population_specificity": "Individuals undergoing eccentric exercise protocols (specific demographics not detailed).", "effective_dosage": "Not specified (studies included fish oil supplementation for \u22657 days).", "study_duration": "\u22657 days (exact duration varied by study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:41.857816+00:00"}
{"study_id": 186959, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether n-3 LCPUFA supplementation, including docosahexaenoic acid (DHA), enhances self-regulation in preschool-aged children.", "results_summary": "The abstract does not provide specific results regarding the effects of DHA supplementation on self-regulation, only describing the study protocol and design.", "population_specificity": "Preschool-aged children (3-5 years old; n = 78; 40 boys and 38 girls).", "effective_dosage": "1.6 g per day (0.3 g EPA and 1.3 g DHA) in microencapsulated powder.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:43.170858+00:00"}
{"study_id": 186963, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to assess whether omega-3 PUFAs (including docosahexaenoic acid) could prevent mood episode relapses in individuals with bipolar disorder.", "results_summary": "The study found no significant differences in mood episode relapses or hospital admissions between the omega-3 PUFA and placebo groups, though there was a minor reduction in hypomania scores in the omega-3 group.", "population_specificity": "Individuals with bipolar disorder (n=80).", "effective_dosage": "1 g DHA plus 1 g EPA daily.", "study_duration": "52 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:44.957933+00:00"}
{"study_id": 186960, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the long-term effects of maternal prenatal supplementation with docosahexaenoic acid (DHA) and 5-methyltetrahydrofolate (5-MTHF) on neural development and function.", "results_summary": "The study assessed the long-term neural effects of prenatal supplementation with DHA and 5-MTHF, but the abstract does not specify conclusive outcomes regarding efficacy. The role of fatty acid desaturase was also examined, but results are not detailed.", "population_specificity": "Pregnant women and their offspring (pre- and early postnatal focus).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:45.914362+00:00"}
{"study_id": 186961, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the oral absorption, bioavailability, and plasma kinetics of a new lysine salt form of EPA and DHA (Lys-FFA) against a commercially available ethyl-ester (EE) supplement.", "results_summary": "The study found that Lys-FFA showed rapid absorption and significantly higher bioavailability of EPA and DHA compared to the EE supplement, with complete dissociation in vitro under simulated gastric and intestinal conditions.", "population_specificity": "Eight female volunteers in a randomized, two-way cross-over design.", "effective_dosage": "500 mg EPA plus 302 mg DHA (Lys-FFA) vs. 504 mg EPA plus 378 mg DHA (EE).", "study_duration": "48-hour plasma profile monitoring.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:46.118094+00:00"}
{"study_id": 186964, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if changes in erythrocyte DHA levels were associated with changes in LDL-C levels and whether omega-3 supplement use affected LDL-C.", "results_summary": "The study found that a 1% increase in erythrocyte DHA was associated with a 1.9 mg/dL reduction in LDL-C, and initiating fish oil supplement use did not increase LDL-C. Similar effects were observed for EPA and EPA + DHA.", "population_specificity": "Predominantly male, normolipidemic, middle-aged individuals (mean age 52.6 years).", "effective_dosage": "Not specified", "study_duration": "Average time between exams was 1.9 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:48.558217+00:00"}
{"study_id": 186965, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to examine the biochemical and physiological effects of n-3 DPA in human and animal studies, focusing on its unique properties and role in inflammation resolution.", "results_summary": "The study found that n-3 DPA increases in blood lipids within 3-4 days of supplementation and has biological functions more similar to DHA than EPA. Unique SPMs derived from n-3 DPA play roles in resolving inflammation and regulating immune function.", "population_specificity": "Human and animal subjects (specific details not provided).", "effective_dosage": "1-2 g/day in human trials.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:49.566209+00:00"}
{"study_id": 186966, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of EPA and DHA supplementation on monocyte inflammatory response and plasma PUFA SPM lipidome in individuals with chronic inflammation.", "results_summary": "DHA supplementation reduced multiple pro-inflammatory cytokines (TNFA, IL6, MCP1, IL10) and showed a broader anti-inflammatory effect than EPA. DHA also significantly altered the plasma PUFA SPM lipidome by increasing EPA derivatives and DPA-derived SPM at the expense of AA derivatives.", "population_specificity": "9 men and 12 postmenopausal women (50-75 years) with chronic inflammation.", "effective_dosage": "3 g/day", "study_duration": "10-week supplementation phases separated by a 10-week washout.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:51.269637+00:00"}
{"study_id": 186970, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to examine the effects of vitamin D and omega-3 supplementation on delaying microvascular and macrovascular complications in adults with type 2 diabetes.", "results_summary": "The abstract does not provide specific results regarding Docosahexaenoic Acid's effects, focusing instead on vitamin D outcomes.", "population_specificity": "US adults with type 2 diabetes, without known cardiovascular disease, malignancy, or end-stage kidney disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:53.729649+00:00"}
{"study_id": 186969, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of n-3 PUFA supplementation, including Docosahexaenoic Acid, on individuals with NAFLD diagnosed by ultrasound.", "results_summary": "The abstract suggests that n-3 PUFA supplementation was associated with improved clinical parameters of NAFLD, though specific results are not detailed. The study was a randomized, double-blind, placebo-controlled trial, indicating robust methodology.", "population_specificity": "Individuals diagnosed with non-alcoholic fatty liver disease (NAFLD) via ultrasound.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:54.436678+00:00"}
{"study_id": 186967, "supplement_id": 1089, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether prenatal DHA supplementation affects neurodevelopment, particularly language abilities, in children up to seven years of age.", "results_summary": "The study found no significant group differences in language, academic, or cognitive abilities between DHA and placebo groups. Exploratory analyses suggested a possible adverse effect on language in females at 1.5 years, but no effects were observed at later ages.", "population_specificity": "Australian women with singleton pregnancies <21 weeks' gestation and their children (including preterm and term births).", "effective_dosage": "800 mg DHA/day", "study_duration": "From randomization (<21 weeks' gestation) until birth", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:55.053621+00:00"}
{"study_id": 186968, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate sex differences in blood fatty acid responses to EPA or DHA supplementation.", "results_summary": "The study found that young adult females had higher baseline blood DHA levels than males, but sex differences in response to EPA or DHA supplementation were not fully explored. Plasma fatty acid levels and carbon-13 signatures were analyzed after 12 weeks of supplementation.", "population_specificity": "Young adult females and males (n = 14-15 per group).", "effective_dosage": "3 g/day EPA or 3 g/day DHA.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:55.305317+00:00"}
{"study_id": 186972, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential of resolvins, including DHA derivatives, in preventing and treating stroke by examining their anti-inflammatory properties.", "results_summary": "The study found that resolvin D2, derived from DHA, reduced brain damage and neurological dysfunction in animal models, decreased proinflammatory cytokines, and showed better effects than DHA supplementation alone in stroke treatment.", "population_specificity": "Animal models (not specified further)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:57.292231+00:00"}
{"study_id": 186971, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if a DHA-dominant supplement could improve performance in amateur cyclists, specifically focusing on mean power output at the ventilatory threshold 2 (VT2).", "results_summary": "DHA supplementation improved mean power output at VT2, both in absolute and relative terms, and increased oxygen consumption at VT2. The findings suggest DHA enhances performance at the anaerobic ventilatory threshold, though the exact mechanism remains unclear.", "population_specificity": "Male amateur competitive cyclists over 18 years old, training 2-4 sessions per week (\u22651 hour each).", "effective_dosage": "975 mg of re-esterified DHA daily.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:43:58.605720+00:00"}
{"study_id": 186973, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a specific Omega-3 index (O3I) level or a minimum daily dose of n-3 LCPUFA (DHA and/or EPA) is required to improve cognition in children and adolescents aged 4-25.", "results_summary": "The study found that cognitive improvement was more likely when the O3I increased to >6% or when daily supplementation included \u2265450 mg DHA + EPA in typically developing children. No clear cut-off was identified for children with disorders.", "population_specificity": "Children and adolescents aged 4-25, including typically developing individuals and those with disorders.", "effective_dosage": "\u2265450 mg DHA + EPA per day", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:00.741924+00:00"}
{"study_id": 186974, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of DHA supplementation during the first 1000 days (pregnancy, preterm infancy, or postpartum) on child language outcomes.", "results_summary": "The review included 29 RCTs assessing DHA supplementation's impact on language development, but the abstract does not specify the overall findings regarding efficacy.", "population_specificity": "Pregnant women, preterm infants, and postpartum individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:01.758677+00:00"}
{"study_id": 186975, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine if long-term DHA supplementation reduces pulmonary, systemic, and intestinal inflammation in cystic fibrosis patients.", "results_summary": "The study found no significant differences in primary or secondary inflammatory biomarkers or clinical outcomes between DHA and placebo groups. DHA supplementation was safe but showed no benefit over placebo.", "population_specificity": "Cystic fibrosis patients (age >2 months, mean age 14.6\u00b111.9 years).", "effective_dosage": "50 mg/kg/day of seaweed DHA oil solution.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:03.782656+00:00"}
{"study_id": 186977, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of omega-3 supplementation, including docosahexaenoic acid (DHA), combined with a multidomain intervention on intrinsic capacity in older adults.", "results_summary": "The study found no significant differences in intrinsic capacity decline between groups receiving DHA supplementation and those receiving placebo, indicating no detectable benefit of DHA in this context. All groups showed similar declines in intrinsic capacity over the 3-year period.", "population_specificity": "Community-dwelling older adults (mean age 75.3 years, 64.2% female).", "effective_dosage": "800 mg DHA and 225 mg eicosapentaenoic acid (EPA) per day.", "study_duration": "3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:04.826544+00:00"}
{"study_id": 186978, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether maternal supplementation with 400 mg/d algal DHA during pregnancy and lactation improves offspring neurodevelopment at 12 months compared to placebo.", "results_summary": "The study found no statistically significant difference in infant neurodevelopment scores at 12 months between the DHA and placebo groups. Serious adverse events were reported but none were related to the intervention.", "population_specificity": "Pregnant Indian women (singleton gestation) from \u226420 weeks through 6 months postpartum.", "effective_dosage": "400 mg/d algal DHA", "study_duration": "From \u226420 weeks gestation through 6 months postpartum", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:05.568868+00:00"}
{"study_id": 186976, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how omega-3 LCPUFA supplementation affects fatty acid and oxylipin concentrations during pregnancy and its potential role in modulating pregnancy duration.", "results_summary": "Omega-3 LCPUFA supplementation increased total DHA and certain DHA-derived oxylipins (7-HDHA, 4-HDHA, 14-HDHA) and mitigated their decline during pregnancy, with minimal effects on other fatty acids. The response was more pronounced in women with higher baseline omega-3 status.", "population_specificity": "1263 pregnant women with singleton pregnancies from the ORIP trial.", "effective_dosage": "Not specified in the abstract.", "study_duration": "From ~14 weeks gestation to 34 weeks gestation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:05.868068+00:00"}
{"study_id": 186979, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review the metabolic effects of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) on inflammation and thrombosis, focusing on divergent results in clinical trials.", "results_summary": "The study found that daily intake of at least 1 g of EPA + DHA may improve dysmetabolic states, but the potential to reduce atherothrombotic heart disease risk remains debated due to variations in study populations, supplement types, EPA/DHA ratios, and trial durations.", "population_specificity": "General population with a focus on metabolic and cardiovascular health.", "effective_dosage": "At least 1 g of EPA + DHA daily.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:07.906825+00:00"}
{"study_id": 186980, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether 6-month supplementation with 300 mg/d DHA improves executive functions (working memory and cognitive flexibility) in healthy school-aged children in rural China.", "results_summary": "The study found no significant benefit of DHA supplementation on executive functions, with no improvement in working memory or cognitive flexibility compared to placebo. Changes in erythrocyte DHA levels also showed no association with EF scores.", "population_specificity": "Healthy school-aged children (7-12 years) in rural China with low dietary omega-3 intake.", "effective_dosage": "300 mg/d DHA", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:09.538574+00:00"}
{"study_id": 186962, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the feasibility of providing concentrated LCPUFA supplements to very low birth weight infants and evaluate blood LCPUFA concentrations at 2 and 8 weeks of supplementation.", "results_summary": "The study found that enteral LCPUFA supplementation, particularly at higher doses (360 mg combined DHA and ARA), significantly increased blood DHA and ARA levels by 2 weeks and sustained these effects at 8 weeks compared to placebo.", "population_specificity": "Very low birth weight infants (median gestational age 28 weeks, median weight 1040 g).", "effective_dosage": "Two doses were tested: LCPUFA-120 (40 mg/kg/day DHA + 80 mg/kg/day ARA) and LCPUFA-360 (120 mg/kg/day DHA + 240 mg/kg/day ARA).", "study_duration": "8 weeks or until discharge, whichever came first.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:09.791918+00:00"}
{"study_id": 186984, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of docosahexaenoic acid triglycerides (TG-DHA) as a novel nutraceutical approach for treating advanced chronic liver disease (ACLD) and portal hypertension.", "results_summary": "The abstract highlights the benefits of TG-DHA supplementation in other health areas and suggests its potential for ACLD and portal hypertension based on pre-clinical data, but does not provide specific results from human trials.", "population_specificity": "Advanced chronic liver disease (ACLD) patients, based on pre-clinical data.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:12.443308+00:00"}
{"study_id": 186986, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review the evidence on the role of omega-3 LCPUFAs (DHA and EPA) in reducing inflammation and their potential benefits in specific patient populations and medical conditions.", "results_summary": "The study found that DHA and EPA reduce inflammation and may benefit cognitive health, muscle mass decline, cancer treatment, surgical patients, and critical illness, though evidence remains inconsistent in some areas due to varying trial factors.", "population_specificity": "Older people, patients with multi-morbidities, and specific medical conditions (e.g., cognitive decline, cancer, surgical patients, critical illness).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:14.786966+00:00"}
{"study_id": 186985, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effect of dietary supplementation with omega-3 PUFA, including docosahexaenoic acid (DHA), in patients with stage III and IV periodontitis.", "results_summary": "The abstract does not provide specific results regarding DHA's effects, but it suggests that omega-3 PUFAs, including DHA, may have anti-inflammatory properties beneficial for treating chronic periodontitis.", "population_specificity": "Thirty otherwise healthy patients with stage III and IV periodontitis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:15.052640+00:00"}
{"study_id": 186987, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether changes in n-3 PUFA levels, including docosahexaenoic acid, were associated with changes in depressive symptoms in overweight, subclinically depressed individuals.", "results_summary": "The study found that multinutrient supplements significantly increased n-3 PUFA levels, including docosahexaenoic acid, but these increases were not associated with changes in depressive symptoms. The supplements did not effectively prevent depressive symptoms in the studied population.", "population_specificity": "Overweight and subclinically depressed persons from four European countries.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:15.616556+00:00"}
{"study_id": 186988, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of maternal supplementation with multiple micronutrients and DHA on maternal biomarkers and infant anthropometric parameters during pregnancy.", "results_summary": "The study assessed changes in maternal red blood cell DHA levels but did not provide specific results in the abstract. The focus was on comparing supplementation with no supplementation during the second and third trimesters.", "population_specificity": "Pregnant women in their second and third trimesters.", "effective_dosage": "Once-daily supplementation (specific dosage not provided).", "study_duration": "Second and third trimesters of pregnancy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:16.166942+00:00"}
{"study_id": 186989, "supplement_id": 1089, "safety_score": "90", "efficacy_score": 20, "quality_score": 80, "study_goal": "The researchers aimed to determine whether 8 weeks of EPA and DHA supplementation could attenuate muscular fatigue caused by repeated knee extensions in healthy men.", "results_summary": "The study found no significant difference in maximal repetitions to exhaustion, muscle oxygen availability, maximum isometric voluntary muscle contraction, or blood lactate levels between the fish oil and placebo groups, indicating that EPA and DHA supplementation did not reduce muscle fatigue.", "population_specificity": "Healthy men", "effective_dosage": "260-mg DHA per day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:17.331523+00:00"}
{"study_id": 186990, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of n-3 LC-PUFAs (including DHA) on apoB100-containing lipoprotein turnover and sphingolipid content in hypertriglyceridemic subjects.", "results_summary": "Supplementation with DHA and EPA reduced VLDL, triglyceride, and apoB100 concentrations, improved lipoprotein conversion rates, and altered sphingolipid content, suggesting a beneficial impact on lipid metabolism.", "population_specificity": "Six subjects with hypertriglyceridemia.", "effective_dosage": "1 g of fish oil 3 times daily (containing 240 mg DHA per dose).", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:19.947885+00:00"}
{"study_id": 186982, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the plasma lipidomic responses to krill oil (KO) versus fish oil (FO) supplementation, focusing on the effects of docosahexaenoic acid (DHA) and other omega-3 PUFAs over 30 days in healthy women.", "results_summary": "KO resulted in a significantly greater relative area under the curve (relAUC) for plasma EPA after 30 days, with 26 of 43 lipid molecular species showing greater relAUC in the KO group. More than 38% of the lipids that increased following KO contained omega-3 PUFA, while only 12% did so in the FO group, indicating KO and FO have non-equivalent effects on the plasma lipidome.", "population_specificity": "Healthy women aged 18-50 years.", "effective_dosage": "0.42 g DHA/day (from KO) and 0.47 g DHA/day (from FO).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:20.329274+00:00"}
{"study_id": 186991, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether higher doses of DHA improve brain bioavailability and whether APOE4 carriers show reduced DHA and EPA delivery to the brain before cognitive impairment.", "results_summary": "The study found a 28% increase in CSF DHA and a 43% increase in CSF EPA in the DHA treatment group compared to placebo, with greater EPA increases in non-APOE4 carriers. However, no significant changes in brain volumes or cognitive scores were observed between groups.", "population_specificity": "33 individuals, including APOE4 carriers and non-carriers, with 26 completing lumbar punctures and MRIs and 29 completing cognitive assessments.", "effective_dosage": "2,152 mg of DHA per day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:22.416458+00:00"}
{"study_id": 186993, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the potential of docosahexaenoic acid (DHA) to reduce inflammation and improve outcomes in SARS-CoV-2 patients, while also assessing its risks.", "results_summary": "DHA and EPA showed anti-inflammatory effects by reducing inflammatory eicosanoids and promoting pro-resolving mediators, potentially aiding recovery in SARS-CoV-2 patients. However, they may also increase oxidative stress due to non-enzymatic oxidation of cell membranes.", "population_specificity": "Critically ill SARS-CoV-2 patients.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:24.029037+00:00"}
{"study_id": 186995, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of omega-3 fatty acids, particularly DHA, in improving symptoms and cognitive functions in schizophrenia patients, focusing on varying developmental phases of the disorder.", "results_summary": "Omega-3 supplementation reduced psychosis conversion rates and improved symptoms in high-risk adolescents, enhanced negative symptoms in first-episode patients, and showed modest benefits in chronic patients, particularly those with low baseline PUFA levels.", "population_specificity": "Adolescents at ultra-high risk for psychosis, first-episode schizophrenia patients, and chronic schizophrenia patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:24.370747+00:00"}
{"study_id": 186992, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether maternal DHA supplementation during the neonatal period improves bronchopulmonary dysplasia-free survival in breastfed infants born before 29 weeks of gestation.", "results_summary": "Maternal DHA supplementation did not significantly improve bronchopulmonary dysplasia-free survival compared to placebo. The DHA group showed higher bronchopulmonary dysplasia rates (41.7% vs. 31.4%) but lower mortality (6.0% vs. 10.2%), though neither difference was statistically significant.", "population_specificity": "Breastfed preterm infants born before 29 weeks of gestation and their lactating mothers.", "effective_dosage": "1.2 g/d of DHA", "study_duration": "From randomization to 36 weeks' postmenstrual age", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:24.457434+00:00"}
{"study_id": 186996, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether DHA-enriched fish oil supplementation improves insulin resistance in a sex-dependent manner.", "results_summary": "The study suggests that DHA may improve insulin resistance, with potential sex-dependent effects, though specific results are not detailed in the abstract.", "population_specificity": "Men and women with abdominal obesity (waist circumference: males \u2265102 cm; females \u226588 cm) and without diabetes, aged 50.9 \u00b1 12.7 years, 63.7% female, BMI 32.4 \u00b1 6.6 kg/m\u00b2.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:25.260626+00:00"}
{"study_id": 186997, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the role of omega-3 fatty acids, particularly Docosahexaenoic Acid (DHA), in preventing pathological calcification (e.g., vascular and cancer-related) and improving bone health.", "results_summary": "The study found that omega-3 fatty acids, including DHA, help prevent pathological calcification in vascular and cancer tissues while improving bone quality by enhancing mineralization and reducing decay. They also suggest benefits for cardiac patients and cancer patients undergoing chemotherapy.", "population_specificity": "Elderly females at risk of osteoporosis, cardiac patients, and cancer patients (particularly breast cancer).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:27.296698+00:00"}
{"study_id": 186999, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify associations between maternal fish oil supplementation (a source of DHA) and infant fatty acid profiles, particularly DHA and omega-3 metabolites, at one year of age.", "results_summary": "Antenatal fish oil supplementation was positively associated with higher DHA and omega-3 metabolite levels in infants at one year, though associations were modest and less robust than those observed with postnatal 25OHD3 levels.", "population_specificity": "Infants (1 year old) from the Barwon Infant Study (n=485).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:28.749190+00:00"}
{"study_id": 186998, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine whether adding docosahexaenoic acid (DHA) to lutein supplementation enhances macular pigment optical density (MPOD) and plasma lutein levels compared to lutein alone.", "results_summary": "The study found that combining DHA with lutein significantly increased MPOD and plasma lutein levels compared to lutein alone, with both outcomes showing high statistical significance (p < 0.0001). DHA also significantly elevated its own levels in red blood cell membranes.", "population_specificity": "100 healthy participants (200 eyes) aged 40-70 years from a Mediterranean population.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:29.991748+00:00"}
{"study_id": 187000, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether docosahexaenoic acid (DHA) supplementation reduces the risk of bronchopulmonary dysplasia (BPD) in preterm infants.", "results_summary": "The meta-analysis of four RCTs found that DHA supplementation did not significantly decrease the risk of BPD at 36 weeks of postmenstrual age in preterm infants, suggesting no substantial clinical benefits for BPD or other neonatal morbidities.", "population_specificity": "Preterm infants with gestational age <33 weeks.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:30.740686+00:00"}
{"study_id": 187002, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to review the role of DHA in brain development, its sources, clinical and pharmacological activities, current formulations, and future prospects.", "results_summary": "The study found that DHA is critical for neural and retinal cell development, exhibits neuroprotective, cardioprotective, and anti-inflammatory properties, and is recommended as a supplement to prevent deficiency-related health deficits. It also highlighted advancements in DHA formulations beyond traditional soft gelatin capsules.", "population_specificity": "General population, with emphasis on prenatal, infant, and adult stages.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:32.250497+00:00"}
{"study_id": 187003, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether supplementing with n-3 PUFAs, including Docosahexaenoic Acid, could increase whole-body resting metabolic rate (RMR) by influencing metabolism and protein function.", "results_summary": "The study suggests that n-3 PUFAs may enhance Na-related mechanisms, potentially increasing RMR, but the abstract does not provide detailed results or statistical significance.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:32.937505+00:00"}
{"study_id": 187001, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine factors contributing to inconsistencies in human intervention studies on docosahexaenoic acid (DHA) and explore potential biomarkers for personalized supplementation.", "results_summary": "The study highlights inconsistencies in human trial outcomes compared to preclinical studies, identifies possible influencing factors (diet, gut microbiota, genetics), and discusses biomarkers for predicting individual responsiveness to DHA. It also reviews studies categorizing subjects as responders or non-responders to omega-3 PUFAs.", "population_specificity": "Not specified (general human population implied)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:33.072114+00:00"}
{"study_id": 187004, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to measure the bioavailability and impact on inflammation of a supplement containing DHA, EPA, and vitamin D in healthy individuals and those with Crohn's disease.", "results_summary": "The study found that the supplement was tested in a double-blinded, randomized, placebo-controlled crossover design, but specific outcomes regarding DHA's effects were not detailed in the abstract.", "population_specificity": "Healthy individuals and those with Crohn's disease.", "effective_dosage": "510 mg DHA, 344 mg EPA, and 1000 IU vitamin D daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:33.553389+00:00"}
{"study_id": 187006, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the relationship between blood levels of DHA and EPA and their correlation with clinical events, as well as the reliability of the Omega-3 Index as a biomarker.", "results_summary": "The study found that while clinical events strongly correlate with blood levels of EPA and DHA, these levels poorly correlate with ingested amounts. The Omega-3 Index in erythrocytes showed low biologic variability when analyzed with a standardized procedure.", "population_specificity": "Pregnant women (implied by the recommendation for increased DHA intake during pregnancy).", "effective_dosage": "200 mg/day (recommended increase during pregnancy).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:36.301637+00:00"}
{"study_id": 187008, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to investigate the effects of omega-3 fatty acids (including docosahexaenoic acid) on hepatic de novo lipogenesis, fatty acid oxidation, and intrahepatocellular triacylglycerol content in healthy men.", "results_summary": "Omega-3 supplementation significantly decreased fasting plasma TAG, intrahepatocellular TAG, and hepatic DNL while increasing dietary fatty acid oxidation and plasma glucose concentrations. In vitro studies supported these findings, showing a shift from fatty acid esterification to oxidation.", "population_specificity": "Healthy men", "effective_dosage": "4 g/day (EPA+DHA as ethyl esters)", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:38.885402+00:00"}
{"study_id": 187009, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of a high-concentration DHA+EPA supplement on strength deficit, inflammatory markers, and muscle damage in endurance athletes after eccentric exercise.", "results_summary": "The study found no significant differences in strength deficit between the supplement and placebo groups, but observed a significant effect on IL1\u03b2 levels, suggesting potential anti-inflammatory benefits.", "population_specificity": "Fifteen endurance athletes.", "effective_dosage": "2.1 g/day DHA + 240 mg/day EPA.", "study_duration": "10 weeks per supplementation period, with a 4-week washout.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:39.025925+00:00"}
{"study_id": 187011, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of fish oil supplements with different EPA/DHA ratios on lipoprotein metabolism, specifically focusing on DHA's impact.", "results_summary": "Both EPA-rich and DHA-rich fish oil supplements similarly lowered plasma triglyceride levels, but differences were observed in lipoprotein subfraction composition and distribution, suggesting potential cardiovascular health implications.", "population_specificity": "Normolipidemic adults (n = 30)", "effective_dosage": "12 g/day", "study_duration": "8 weeks per intervention, separated by an 8-week washout", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:40.984166+00:00"}
{"study_id": 187010, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of an omega-3 fatty acid fish oil emulsion versus a control oil emulsion as an adjuvant therapy for depressive disorders in children and adolescents, while analyzing serum fatty acid levels and omega-6/omega-3 ratios.", "results_summary": "The study found significant reductions in depression scores (CDI) after 6 and 12 weeks in the omega-3 group, particularly in the depressive disorder subgroup. The omega-6/omega-3 ratio decreased significantly in the omega-3 group, and baseline EPA and omega-6/omega-3 ratios correlated with symptom severity.", "population_specificity": "Children and adolescents with depressive disorder (DD) or mixed anxiety depressive disorder (MADD).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:41.727622+00:00"}
{"study_id": 187012, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of EPA/DHA versus ALA supplementation on cardiometabolic disturbances, particularly focusing on cardiovascular risk factors.", "results_summary": "EPA/DHA supplementation led to greater reductions in triglycerides (TG) and increases in high-density lipoprotein (HDL) but also raised low-density lipoprotein (LDL) and total cholesterol (TC) compared to ALA. Subgroup analyses showed stronger TG reductions in participants over 40 and modest HDL increases with DHA but not EPA.", "population_specificity": "1,137 participants from 14 RCTs, with subgroup analysis for those >40 years old.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:42.352306+00:00"}
{"study_id": 187013, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the current literature on the effects of fish oil (containing EPA and DHA) supplementation on muscle mass in patients with chronic diseases, particularly cancer and COPD.", "results_summary": "The evidence for fish oil's effect on muscle mass in cancer patients undergoing treatment and in COPD patients remains unclear, with mixed results reported in recent studies. The review highlights challenges in comparing and interpreting these studies.", "population_specificity": "Patients with various cancers (gastrointestinal, breast, head and neck, lung, cervix, hematological) and chronic obstructive pulmonary disease (COPD).", "effective_dosage": "Not specified (fish oil provided as part of nutrient mixtures in 12 studies and as capsules in three studies).", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:43.058602+00:00"}
{"study_id": 187014, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of DHA supplementation on cognitive performance in euthymic bipolar disorder patients compared to healthy controls.", "results_summary": "The study found no significant differences in cognitive performance between groups after 12 weeks of DHA supplementation, except for higher scores in healthy controls on the emotion inhibition test. Plasma DHA levels were measured but did not correlate with cognitive improvements.", "population_specificity": "Euthymic bipolar disorder patients (n=31) and healthy controls (n=15).", "effective_dosage": "1250 mg daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:44.451277+00:00"}
{"study_id": 187017, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether inflammatory state modulates the effect of omega-3 LCPUFA (including docosahexaenoic acid) and vitamin D on core symptoms of autism spectrum disorder (ASD) in children.", "results_summary": "The study found that baseline inflammatory state (specifically IL-1\u03b2 levels) influenced treatment response, suggesting children with elevated inflammation may benefit more from omega-3 LCPUFA and vitamin D supplementation in improving ASD symptoms.", "population_specificity": "Children with autism spectrum disorder (ASD)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:46.942476+00:00"}
{"study_id": 187015, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to examine the relationship between basal PUFA composition (including docosahexaenoic acid) and impulsivity in individuals with gambling disorder.", "results_summary": "The study found that impulsive gamblers had a lower AA/DHA ratio in erythrocyte membranes compared to non-impulsive gamblers, suggesting a potential link between DHA levels and impulsivity. However, the direction of this relationship remains unclear.", "population_specificity": "Fifty-five men with gambling disorder.", "effective_dosage": "Not specified (basal composition assessed, not supplementation).", "study_duration": "Not specified (cross-sectional study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:47.491364+00:00"}
{"study_id": 187018, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify the researchers' goal regarding Docosahexaenoic Acid.", "results_summary": "The abstract does not provide results related to Docosahexaenoic Acid.", "population_specificity": "Not specified in the provided abstract.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:47.495630+00:00"}
{"study_id": 187019, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of omega-3 supplementation, including docosahexaenoic acid (DHA), on cognitive test performance in youths.", "results_summary": "The meta-analysis found no main effect of omega-3 fatty acid supplementation, including DHA-rich formulations, on domain-specific cognitive test performance in youths. Subgroup analyses indicated beneficial effects of EPA-rich but not DHA-rich formulations in certain cognitive domains.", "population_specificity": "Youths (clinical and non-clinical populations)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:49.835505+00:00"}
{"study_id": 187020, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "To investigate whether DHA supplementation prevents or slows age-related cognitive decline in specific cognitive domains (memory, attention, working memory, and executive function).", "results_summary": "The meta-analysis of 10 studies involving 2327 elderly individuals found minimal or no significant effects of DHA supplementation on memory, executive function, attention, or working memory. The evidence does not support DHA's role in preventing or retarding age-related cognitive decline.", "population_specificity": "Elderly individuals (specific age range not provided).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:51.066623+00:00"}
{"study_id": 187021, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether fish oil supplementation (containing EPA and DHA) reduces subclinical inflammation and improves cardiometabolic risk in hypertensive patients.", "results_summary": "Fish oil supplementation significantly reduced TNF-\u03b1 and CRP levels, improved cardiometabolic risk scores, and increased erythrocyte n-3 FA levels, suggesting anti-inflammatory and cardioprotective effects. No significant change was observed in IL-6 levels.", "population_specificity": "Middle-aged/elderly hypertensive patients from Inner Mongolia.", "effective_dosage": "2 g/day (combined EPA + DHA).", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:51.625072+00:00"}
{"study_id": 187022, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify whether baseline omega-3 PUFA status could predict which pregnant women would benefit from omega-3 supplementation to reduce early preterm birth risk.", "results_summary": "Women with low total omega-3 PUFA status (\u22644.1%) had a higher risk of early preterm birth, which was significantly reduced by omega-3 supplementation. Conversely, women with higher omega-3 status (>4.9%) saw an increased risk of early preterm birth with supplementation.", "population_specificity": "Women with singleton pregnancies enrolled in the ORIP trial across six Australian hospitals.", "effective_dosage": "Not specified", "study_duration": "Supplementation began at ~14 weeks' gestation; duration not explicitly stated.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:53.727948+00:00"}
{"study_id": 187024, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the therapeutic and health-promoting effects of omega-3 and omega-6 PUFAs, including Docosahexaenoic Acid, in managing inflammatory skin diseases.", "results_summary": "The study found that combined omega-6 (GLA) and omega-3 PUFAs supplementation shows potential in reducing inflammatory processes, which may benefit conditions like atopic dermatitis, psoriasis, and acne. However, results were inconclusive due to genetic variations affecting PUFA metabolism and inflammatory responses.", "population_specificity": "Individuals with inflammatory skin diseases (e.g., atopic dermatitis, psoriasis, acne) and general population for skin health maintenance.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:56.478879+00:00"}
{"study_id": 187026, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of DHA supplementation on oxylipins and unesterified fatty acids during pregnancy and its potential role in reducing preterm birth risk.", "results_summary": "DHA supplementation increased levels of unesterified DHA, EPA, AA, and certain oxylipins, and higher levels of specific oxylipins and unesterified AA were associated with increased preterm birth risk.", "population_specificity": "Pregnant Australian women (subset of 48 participants from the ORIP study).", "effective_dosage": "Daily supplementation (exact dosage not specified in abstract).", "study_duration": "From \u2248week 14 to \u2248week 24 of pregnancy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:56.756511+00:00"}
{"study_id": 187023, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the effects of high-dose omega-3 (including Docosahexaenoic Acid) and omega-6 fatty acids, combined with antioxidant vitamins, on cognitive function and functional capacity in older adults with mild cognitive impairment (MCI).", "results_summary": "The study found a significant interaction between supplementation and time on cognitive function, as measured by tests like the ACE-R, MMSE, and STROOP color test, suggesting potential benefits of the supplement for cognitive performance in MCI patients.", "population_specificity": "Older adults (mean age 78.8 \u00b1 7.3 years) with mild cognitive impairment (MCI).", "effective_dosage": "4140 mg Docosahexaenoic Acid (DHA) per 20 mL dose, administered daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:44:57.355234+00:00"}
{"study_id": 187029, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether LCn-3PUFA supplementation improves cognitive function in non-demented adults, including those with mild cognitive impairment.", "results_summary": "The study found no significant effect of LCn-3PUFAs on global cognitive function but observed a mild benefit in memory function. The pooled effect sizes indicated negligible impact overall, with memory showing a small but statistically significant improvement.", "population_specificity": "Non-demented adults, including those with mild cognitive impairment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:00.326280+00:00"}
{"study_id": 187027, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the therapeutic differences between prescription omega-3 fatty acids (including Docosahexaenoic Acid) and dietary supplements, focusing on safety, efficacy, and regulatory standards.", "results_summary": "The study found that prescription omega-3 products, including EPA-only formulations, demonstrated cardiovascular risk reduction in high-risk patients, while dietary supplements showed inconsistent or insufficient evidence for clinical benefits. Prescription omega-3s are indicated for specific conditions like severe hypertriglyceridemia and cardiovascular risk reduction, whereas dietary supplements suffer from quality and labeling inconsistencies.", "population_specificity": "Adults with severe hypertriglyceridemia (TG \u2265 500 mg/dL) or high cardiovascular risk (elevated TG \u2265 150 mg/dL with established CVD or diabetes and additional risk factors).", "effective_dosage": "Not specified for Docosahexaenoic Acid.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:00.530311+00:00"}
{"study_id": 187028, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of omega-3 fatty acids (including Docosahexaenoic Acid) and vitamin D on glycemic indices, lipid profiles, and other cardiometabolic risk factors in prediabetic women with hypovitaminosis D.", "results_summary": "The study did not report specific results for Docosahexaenoic Acid alone, but it investigated its co-supplementation with vitamin D on fasting blood sugar, lipid profiles, and psychological distress in prediabetic women. The abstract suggests the trial will provide evidence on efficacy but does not detail outcomes.", "population_specificity": "Reproductive-aged women with prediabetes and hypovitaminosis D.", "effective_dosage": "1000 mg omega-3 fatty acid (including Docosahexaenoic Acid) twice a day.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:01.491371+00:00"}
{"study_id": 187032, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine if prenatal DHA supplementation increased markers of insulin sensitivity in maternal or cord blood compared to placebo.", "results_summary": "DHA supplementation had no effect on plasma markers of insulin sensitivity compared to placebo, but higher maternal serum DHA fraction was associated with increased insulin sensitivity markers. Cord blood DHA fraction was linked to cord plasma leptin levels.", "population_specificity": "126 women with singleton pregnancies between 12- and 20-weeks' gestation.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Supplementation from 12-20 weeks gestation until 34-36 weeks gestation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:05.363994+00:00"}
{"study_id": 187031, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to establish the relationship between omega-3 fatty acid supplementation (including docosahexaenoic acid) and peripheral specialized pro-resolving mediator (SPM) concentrations, as well as its effects on peripheral blood cell responses.", "results_summary": "The study found that supplementation with an enriched marine oil led to a time- and dose-dependent increase in SPM concentrations, enhanced neutrophil and monocyte phagocytosis, reduced leukocyte and platelet activation, and altered immune and metabolic gene transcription.", "population_specificity": "Healthy volunteers", "effective_dosage": "Three doses of an enriched marine oil supplement (specific amounts not detailed in the abstract)", "study_duration": "Blood collected at baseline, 2, 4, 6, and 24 hours post-administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:06.143269+00:00"}
{"study_id": 187033, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of genetic background in the variability of insulin sensitivity response following n-3 PUFA (including docosahexaenoic acid) supplementation.", "results_summary": "The study found that 23.2% of participants experienced increased insulin resistance (HOMA-IR) after n-3 PUFA supplementation, with genetic risk scores explaining 40% of the variation in response. The genetic risk score showed significant predictive accuracy (OR = 3.16) for identifying individuals at risk of worsened insulin sensitivity.", "population_specificity": "210 participants (138 with genome-wide genotyping data)", "effective_dosage": "5 g/day of fish oil (providing 1.9-2.2 g EPA + 1.1 g DHA)", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:07.374942+00:00"}
{"study_id": 187036, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the incorporation of DHA into various blood lipid fractions and its effects on plasma metabolomics profiles in healthy subjects.", "results_summary": "Supplemental DHA significantly increased DHA concentrations in plasma phospholipids and triglyceride fractions by day 6, and elevated sphingosine 1-phosphate levels were observed.", "population_specificity": "Twelve healthy female subjects.", "effective_dosage": "1 g per day.", "study_duration": "6 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:09.438029+00:00"}
{"study_id": 187034, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the impact of fish oil (FO) supplementation, containing docosahexaenoic acid, on cytokine production in patients with intestinal failure on home parenteral nutrition.", "results_summary": "FO supplementation reduced LPS-stimulated production of IL-1\u03b2 and IL-8 under different lipid emulsion regimens and lowered serum IL-8 concentration. It also suppressed IL-6 and TNF-\u03b1 production in patients on Smoflipid.", "population_specificity": "Patients with intestinal failure on home parenteral nutrition (HPNPs).", "effective_dosage": "Not specified (Omegaven was administered for 4 weeks).", "study_duration": "4 weeks of Omegaven, followed by 6-week cycles of other lipid emulsions with additional 4-week Omegaven supplementation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:10.541978+00:00"}
{"study_id": 187035, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether daily marine \u03c9-3 fatty acid supplementation, including docosahexaenoic acid, reduces the risk of colorectal cancer precursors such as conventional adenomas and serrated polyps.", "results_summary": "The study found no significant association between marine \u03c9-3 supplementation and reduced risk of colorectal cancer precursors overall, though potential benefits were noted in individuals with low baseline \u03c9-3 levels and African American participants.", "population_specificity": "25,871 adults in the US general population, including 5,106 African American individuals, free of cancer and cardiovascular disease at enrollment.", "effective_dosage": "1 g daily (containing 380 mg docosahexaenoic acid).", "study_duration": "Median follow-up of 5.3 years (range, 3.8-6.1 years).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:12.170343+00:00"}
{"study_id": 187039, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether n-3 PUFAs, including docosahexaenoic acid (DHA), could improve clinical outcomes in individuals at ultra-high risk for psychotic disorders.", "results_summary": "Increases in n-3 index, EPA, and DHA levels predicted less severe psychopathology and better functioning at follow-up. Higher baseline levels and increases in n-3 PUFAs were associated with overall clinical improvement at 6 and 12 months.", "population_specificity": "218 individuals at ultra-high risk for psychotic disorders.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months (with follow-up at 12 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:14.941625+00:00"}
{"study_id": 187038, "supplement_id": 1089, "safety_score": "70", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids (including docosahexaenoic acid) could prevent the development or progression of chronic kidney disease in adults with type 2 diabetes.", "results_summary": "The study found no significant difference in the change in estimated glomerular filtration rate (eGFR) between participants taking omega-3 fatty acids and those on placebo after 5 years. Gastrointestinal bleeding was more frequent in the omega-3 group compared to placebo.", "population_specificity": "Adults with type 2 diabetes (mean age 67.6 years, 46% women, 31% racial or ethnic minority).", "effective_dosage": "1 g/day (combined eicosapentaenoic acid and docosahexaenoic acid).", "study_duration": "5 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:15.496441+00:00"}
{"study_id": 187040, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether 8 weeks of EPA and DHA supplementation could prevent endothelial dysfunction caused by prolonged sitting.", "results_summary": "The study found that popliteal artery blood flow and shear rate were similarly reduced in both the EPA+DHA and placebo groups during sitting, suggesting no significant preventive effect of the supplementation on sitting-induced endothelial dysfunction.", "population_specificity": "19 healthy men", "effective_dosage": "600 mg EPA and 260 mg DHA per day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:16.065990+00:00"}
{"study_id": 187041, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the association between red blood cell DHA-EPA concentration and psychotropic drug use in older adults, as well as the impact of changes in DHA-EPA levels on psychotropic drug use over 12 months.", "results_summary": "The study found that lower RBC DHA-EPA concentrations were associated with higher psychotropic drug use, particularly anxiolytic/hypnotics and antidepressants. Participants who increased their DHA-EPA levels were less likely to use psychotropic drugs at 12 months compared to those with no change or a decrease.", "population_specificity": "1680 community-dwelling adults aged 70 years and older in France.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:19.544960+00:00"}
{"study_id": 187044, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to update the understanding of the n-3 PUFA biosynthesis pathway, focusing on DHA synthesis rates, its role as both a product and precursor, and the mechanism behind EPA increases in response to DHA supplementation.", "results_summary": "The study found that DHA synthesis rates are higher than previously believed, DHA serves as both a product and precursor to tetracosahexaenoic acid, and EPA increases from DHA supplementation are not due to retroconversion.", "population_specificity": "Rodents and humans", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:23.128359+00:00"}
{"study_id": 187007, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the evidence supporting the antitumor effects of omega-3 PUFAs, including docosahexaenoic acid, in triple-negative breast cancer (TNBC).", "results_summary": "The study found that omega-3 PUFAs, including docosahexaenoic acid, can induce apoptosis in breast cancer cells by inhibiting the PI3K/AKT pathway and may enhance the effectiveness of chemotherapy drugs, particularly in TNBC. However, clinical evidence supporting these effects is lacking.", "population_specificity": "Triple-negative breast cancer (TNBC) patients and preclinical models (In Vivo and In Vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:23.340575+00:00"}
{"study_id": 187043, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of marine omega-3 fatty acids, including docosahexaenoic acid (DHA), on cardiovascular disease (CVD) events in both primary and secondary prevention populations.", "results_summary": "The study found that high-dose purified omega-3 supplementation (4 g/day) significantly reduced major adverse CV events by 25% in patients with coronary heart disease (CHD). Lower doses (840 mg/day EPA+DHA) also reduced risks of CHD and CV death, particularly in individuals with low fish/seafood intake.", "population_specificity": "Patients with CHD (secondary prevention) and primary prevention populations with low fish/seafood consumption.", "effective_dosage": "4 g/day (highly purified omega-3 product) for CHD patients; ~1 g/day (840 mg EPA+DHA) for primary prevention.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:23.393212+00:00"}
{"study_id": 187045, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine if DHA supplementation enhances the efficacy of neoadjuvant chemotherapy in breast cancer patients by assessing changes in Ki67 index and other secondary outcomes.", "results_summary": "The abstract does not provide results, as the study is ongoing. The trial is designed to evaluate DHA's impact on Ki67 index, immune function, tumor markers, pCR rates, toxicities, and quality of life.", "population_specificity": "52 women prescribed neoadjuvant chemotherapy for breast cancer.", "effective_dosage": "4.4 g/day DHA orally.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:24.717730+00:00"}
{"study_id": 187046, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether short-term omega-3 fatty acid supplementation (including docosahexaenoic acid) impacts hepatic steatosis differently in individuals with the PNPLA3 p.148M variant compared to wild-type individuals.", "results_summary": "Short-term omega-3 fatty acid supplementation did not significantly alter hepatic steatosis in either group. However, the PNPLA3 p.148M variant group showed a marked increase in serum free fatty acids (FFA), while the wild-type group exhibited a significant decrease in FFA.", "population_specificity": "Twenty subjects with hepatic steatosis (50% women, age 18-77 years), including 10 homozygous for the PNPLA3 p.148M variant and 10 wild-type individuals.", "effective_dosage": "4 g omega-3 fatty acids daily (1,840 mg eicosapentaenoic acid and 1,520 mg docosahexaenoic acid).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:31.782336+00:00"}
{"study_id": 187048, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether long-term omega-3 PUFA supplementation, alone or combined with a multidomain lifestyle intervention, improved muscle strength in older adults.", "results_summary": "The study found that low-dose omega-3 PUFA supplementation, either alone or combined with a multidomain intervention, had no significant effects on muscle strength over three years in elderly participants.", "population_specificity": "Non-demented adults aged 70 years or older recruited from memory clinics in France and Monaco.", "effective_dosage": "800 mg DHA and 225 mg EPA daily (two capsules per day).", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:31.894404+00:00"}
{"study_id": 187047, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential benefits of docosahexaenoic acid (DHA) and other n-3 PUFAs in reducing cardiovascular mortality, hospitalization, and improving heart function in heart failure patients.", "results_summary": "The study found that n-3 PUFA supplementation significantly reduced cardiovascular mortality and hospitalization in heart failure patients. It also suggested potential benefits in suppressing ventricular remodeling, improving systolic and diastolic function, and offering cardioprotective mechanisms such as anti-inflammatory effects and modulation of autonomic nervous system activity.", "population_specificity": "Heart failure patients (both ischemic and non-ischemic).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:32.554794+00:00"}
{"study_id": 187042, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Docosahexaenoic Acid (DHA) in brain health across the lifespan, focusing on its structural and functional contributions to fetal and infant brain development, adult brain maintenance, and cognitive decline prevention.", "results_summary": "The study found that DHA is crucial for brain membrane structure, neurogenesis, synaptic plasticity, and cognitive function, with circulating plasma DHA levels linked to cognitive abilities during aging and inversely associated with cognitive decline.", "population_specificity": "Fetuses, infants, and adults (general brain health focus).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:32.623742+00:00"}
{"study_id": 187052, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether the increase in plasma EPA following DHA supplementation in humans occurs via retroconversion or slowed metabolism, using carbon-13 isotopic abundance to track n-3 PUFA metabolism.", "results_summary": "DHA supplementation increased plasma EPA concentrations by 130%, but this was due to slowed metabolism rather than retroconversion. EPA supplementation significantly increased plasma EPA and DPAn-3 concentrations and showed substantial conversion of EPA into DHA.", "population_specificity": "Participants aged 21.6 \u00b1 2.2 years.", "effective_dosage": "~3 g/d DHA or EPA.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:33.709225+00:00"}
{"study_id": 187051, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether n-3 LCPUFA (including docosahexaenoic acid) supplementation has a positive effect on cognitive decline in aged and elderly populations.", "results_summary": "Ten out of fourteen reviewed RCTs showed positive outcomes in at least one cognitive domain, suggesting that omega-3 supplementation may improve cognitive function. However, contradictory findings in the literature make definitive conclusions difficult.", "population_specificity": "Aged adults and elderly individuals with or without mild cognitive impairment (MCI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:35.126987+00:00"}
{"study_id": 187049, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of omega-3 PUFAs, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), in improving depression symptoms.", "results_summary": "The meta-analysis found that DHA-pure and DHA-major formulations did not demonstrate significant benefits for depression symptoms, whereas EPA formulations showed clinical benefits. Omega-3 PUFAs with \u226560% EPA at \u22641 g/d were effective in improving depression.", "population_specificity": "2160 participants across 26 studies, focusing on individuals with depression.", "effective_dosage": "EPA formulations at \u22641 g/d were effective; DHA dosage specifics not highlighted.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:36.343606+00:00"}
{"study_id": 187054, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the preconditioning effects of thyroid hormone on liver ischemia-reperfusion injury.", "results_summary": "The abstract does not provide results related to Docosahexaenoic Acid.", "population_specificity": "Not specified in the provided abstract.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:39.100946+00:00"}
{"study_id": 187055, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of docosahexaenoic acid (DHA) and other omega-3 fatty acids on cardiovascular health, focusing on primary and secondary prevention of cardiovascular events.", "results_summary": "The study highlights conflicting results from prior trials on DHA's cardiovascular benefits but notes recent evidence, such as the REDUCE-IT trial, showing significant reductions in cardiovascular mortality and ischemic events in high-risk patients. The abstract suggests a need for further research to clarify DHA's role in specific cardiovascular disease subtypes.", "population_specificity": "Patients with prior coronary artery disease, stroke, major vascular events, or diabetes, particularly those with elevated triglycerides.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:42.089753+00:00"}
{"study_id": 187057, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether maternal DHA supplementation could reduce inflammatory markers in extremely preterm infants through breastmilk.", "results_summary": "Maternal DHA supplementation (200 or 1000 mg/day) led to decreased inflammatory markers in both maternal and infant plasma, correlating with higher red blood cell DHA levels. The findings suggest DHA delivered via breastmilk may reduce infant inflammation.", "population_specificity": "Mother/infant dyads (n=27) with extremely preterm infants.", "effective_dosage": "200 or 1000 mg/day of DHA.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:42.591307+00:00"}
{"study_id": 187053, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the postprandial plasma lipidomic responses to krill oil (KO) and fish oil (FO) supplementation, focusing on the incorporation of long-chain \u03c9-3 polyunsaturated fatty acids like docosahexaenoic acid (DHA) into blood lipid fractions.", "results_summary": "The study found that KO supplementation led to greater concentrations of 5 out of 34 lipid classes compared to FO, with 27 molecular species showing significant differences. DHA from KO was preferentially partitioned toward phospholipids, while DHA from FO was more associated with neutral lipids.", "population_specificity": "Healthy women aged 18-45 years.", "effective_dosage": "5 g of KO or FO supplemented with a high-fat breakfast.", "study_duration": "Single-dose intervention with postprandial measurements at 3 and 5 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:42.876192+00:00"}
{"study_id": 187056, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine if high-dose DHA supplementation in preterm infants (<33 weeks gestation) reduces the incidence and severity of parent-reported allergic disease symptoms by age 7 compared to standard-dose DHA.", "results_summary": "High-dose DHA supplementation did not reduce allergic disease symptoms (wheeze, rhinitis, rhinoconjunctivitis, eczema) or their severity at age 7 or from birth to age 7 compared to standard-dose DHA. No significant differences were observed between the two groups.", "population_specificity": "Preterm infants born at <33 weeks gestation.", "effective_dosage": "High-DHA (~1% total fatty acids) vs. standard-DHA (~0.3% total fatty acids) enteral feeds.", "study_duration": "From 2-4 days postnatal age until 40 weeks postmenstrual age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:43.263516+00:00"}
{"study_id": 187030, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of DHA-rich fish oil supplementation on PPAR-\u03b3 activity and mRNA expression levels of p53 and NF-\u03baB in patients with type 2 diabetes mellitus.", "results_summary": "The study found that 8 weeks of DHA-rich fish oil supplementation significantly increased PPAR-\u03b3 activity in PBMCs of T2DM patients compared to placebo, but no significant changes were observed in p53 or NF-\u03baB mRNA expression levels.", "population_specificity": "Patients with type 2 diabetes mellitus aged 30-70 years.", "effective_dosage": "2400 mg/d DHA-rich fish oil.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:44.013846+00:00"}
{"study_id": 187058, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify factors associated with plasma PUFA levels, including docosahexaenoic acid (DHA), in 3-month-old Tanzanian infants and their mothers.", "results_summary": "Infant plasma DHA levels were positively associated with maternal DHA levels but lower for twin births. Higher maternal n-6 PUFA levels and greater birth weight were associated with higher infant n-6 PUFA levels, while maternal MUFA levels, MUAC, and male sex were associated with lower infant n-6 PUFA levels.", "population_specificity": "3-month-old Tanzanian infants (n=238) and their mothers (n=193).", "effective_dosage": "Not specified", "study_duration": "Cross-sectional study at 3 months postpartum", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:45.089364+00:00"}
{"study_id": 187059, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 65, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the long-term cognitive and behavioral effects of prenatal DHA supplementation on children, following previous findings of reduced early preterm birth and improved infant visual attention.", "results_summary": "Prenatal DHA supplementation reduced early preterm birth and improved infant visual attention, but no consistent long-term cognitive or behavioral benefits were observed. Maternal blood DHA increases were linked to higher IQ scores at ages 5-6, but this effect disappeared after controlling for socioeconomic status.", "population_specificity": "Pregnant women in the US, starting supplementation at 14.5 weeks of gestation, and their children followed up to age 6.", "effective_dosage": "600 mg/d", "study_duration": "From 14.5 weeks of gestation until delivery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:46.583751+00:00"}
{"study_id": 187060, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether supplementation with EPA and DHA could reduce muscle stiffness and damage in the biceps brachii after eccentric contractions.", "results_summary": "The study found that EPA and DHA supplementation significantly improved muscle function (MVC torque and ROM) and reduced muscle soreness, swelling, and stiffness compared to placebo after eccentric contractions.", "population_specificity": "Sixteen healthy men.", "effective_dosage": "600 mg EPA and 260 mg DHA per day.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:47.011177+00:00"}
{"study_id": 187061, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether omega-3 supplementation, including Docosahexaenoic Acid, could mitigate disuse-mediated mitochondrial dysfunction and muscle atrophy.", "results_summary": "The study found that omega-3 supplementation attenuated immobilization-induced muscle atrophy, suggesting a potential role in mitigating mitochondrial dysfunction, though the exact mechanisms remain unclear.", "population_specificity": "Healthy young women (age = 22 \u00b1 3 years)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:49.644220+00:00"}
{"study_id": 187063, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether n-3 PUFAs, including DHA, could improve depressive symptoms in patients with cardiovascular diseases comorbid with major depressive disorder.", "results_summary": "Overall, n-3 PUFAs did not significantly reduce depressive symptoms compared to placebo, but they showed benefits in specific subgroups, such as those with very severe depression, where core symptoms improved.", "population_specificity": "59 patients (64% male, mean age 61.5 years) with cardiovascular diseases and comorbid major depressive disorder.", "effective_dosage": "2 g EPA and 1 g DHA per day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:52.687277+00:00"}
{"study_id": 187064, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine the role of DHA in childhood neurodevelopment, particularly its potential to prevent or mitigate ASD and ADHD.", "results_summary": "Lower DHA levels were associated with increased risk and severity of ASD and ADHD, while higher DHA status at birth correlated with better neurodevelopmental outcomes. Prenatal DHA supplementation showed mixed results, possibly influenced by socio-economic and lifestyle factors.", "population_specificity": "Children with ASD and ADHD, and pregnant women (for prenatal supplementation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:52.689832+00:00"}
{"study_id": 187065, "supplement_id": 1089, "safety_score": "100", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the long-term safety and efficacy of 600 mg/day oral DHA supplementation in patients with Spinocerebellar Ataxia 38 (SCA38).", "results_summary": "The study found significant maintenance of clinical symptom improvement, sustained increase in cerebellar metabolism, and no worsening of neurophysiological parameters over a 2-year period, with no reported side effects.", "population_specificity": "Nine patients with Spinocerebellar Ataxia 38 (SCA38).", "effective_dosage": "600 mg/day oral DHA.", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:53.063436+00:00"}
{"study_id": 187062, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether baseline plasma homocysteine levels influence the cognitive effects of omega-3 fatty acid supplementation in patients with moderate Alzheimer's disease.", "results_summary": "Omega-3 supplementation improved cognitive performance (measured by MMSE) and clinical status (measured by CDRsob) in patients with homocysteine levels below 11.7\u03bcmol/L, but not in those with higher levels. No significant effect was observed on ADAS-cog.", "population_specificity": "171 community-based patients with moderate Alzheimer's disease (MMSE \u226515).", "effective_dosage": "1.7g docosahexaenoic acid and 0.6g eicosapentaenoic acid daily.", "study_duration": "6 months.", "interactions": "Interaction with B vitamin status (homocysteine levels) noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:53.089193+00:00"}
{"study_id": 187067, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential harms of docosahexaenoic acid (DHA) supplementation for preterm neonates, as part of broader efforts to identify medical overuse.", "results_summary": "The study identified DHA supplementation for preterm neonates as a cautionary example of an intervention adopted without full understanding of potential harms, suggesting it may contribute to medical overuse.", "population_specificity": "Preterm neonates", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:54.681126+00:00"}
{"study_id": 187068, "supplement_id": 1089, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine the independent effects of DHA on resting blood pressure and muscle sympathetic nerve activity compared to EPA and olive oil.", "results_summary": "DHA supplementation reduced systolic and diastolic blood pressure more effectively than EPA, with effects similar to olive oil, but increased muscle sympathetic nerve activity, suggesting a vascular mechanism for BP reduction.", "population_specificity": "86 healthy young men and women.", "effective_dosage": "~3 g/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:54.907161+00:00"}
{"study_id": 187066, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether prenatal DHA supplementation could lower childhood blood pressure, specifically in children who were overweight or obese.", "results_summary": "Maternal DHA intake during pregnancy mitigated the association between childhood overweight/obesity and higher blood pressure, with statistically significant lower systolic and diastolic blood pressure in overweight/obese children whose mothers received DHA compared to placebo. No differences were found between DHA-exposed overweight/obese children and non-overweight children.", "population_specificity": "Pregnant women and their children followed up until age 6.", "effective_dosage": "600 mg per day of DHA, administered in 3 capsules daily.", "study_duration": "From a mean of 14.5 weeks' gestation until birth.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:55.407172+00:00"}
{"study_id": 187071, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of EPA + DHA supplementation combined with lifestyle modification on improving metabolic markers and functional capacity in women with overweight.", "results_summary": "The combination of LSM and EPA + DHA supplementation reduced body weight, waist circumference, and body fat while improving functional capacity. It also mitigated negative effects of LSM on IL6 and adiponectin levels.", "population_specificity": "Women with overweight", "effective_dosage": "1.5 g/day (containing ~0.6 g EPA + DHA)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:00.966143+00:00"}
{"study_id": 187070, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of \u03c9-3 intake/supplementation on muscle/lean mass and physical function in young and older adults.", "results_summary": "The evidence is mixed regarding \u03c9-3 supplementation's effects on muscle mass in sedentary young and older adults, with equivocal results when combined with resistance training. Conflicting evidence exists on its benefits for muscle function in older adults, and more studies are needed for definitive conclusions.", "population_specificity": "Young and older adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:01.038965+00:00"}
{"study_id": 187069, "supplement_id": 1089, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential benefits of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in preventing or reversing albuminuria in diabetic subjects, particularly at early stages of the disease.", "results_summary": "The study found that EPA and DHA supplementation for one year slowed the progression of early-stage albuminuria in diabetic subjects with coronary artery disease, with a three-fold higher likelihood of ACR reduction compared to controls. Some participants even transitioned from microalbuminuria (ACR >30 \u03bcg/mg) to normal levels (ACR <30 \u03bcg/mg).", "population_specificity": "Diabetic subjects with clinical coronary artery disease, most with ACR <30 \u03bcg/mg, on ACE inhibitors or angiotensin-receptor blockers.", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:02.153971+00:00"}
{"study_id": 187072, "supplement_id": 1089, "safety_score": "75", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effects of SQ-LNS-plus, containing docosahexaenoic acid (DHA), on linear growth, psychomotor development, iron status, and morbidity in infants aged 6 to 12 months.", "results_summary": "SQ-LNS-plus showed a transient positive effect on linear growth at 8 and 10 months, improved locomotor development, and enhanced hemoglobin concentration, reducing anemia and iron deficiency. However, it increased the incidence of diarrhea, vomiting, and rash/sores.", "population_specificity": "Infants aged 6 to 12 months consuming a maize-based complementary diet.", "effective_dosage": "Not specified (daily consumption of SQ-LNS-plus).", "study_duration": "6 months (from age 6 to 12 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:03.752349+00:00"}
{"study_id": 56468, "supplement_id": 1114, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the relevant literature on the potential role of essential oils in the management of Alzheimer's disease.", "results_summary": "The abstract does not provide specific findings regarding essential oils' effects on Alzheimer's disease.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:10.755914+00:00"}
{"study_id": 56472, "supplement_id": 1114, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the biochemical and pharmacological applications of essential oils, particularly their potential in cancer prevention therapy.", "results_summary": "The review highlighted the diverse medicinal properties of essential oils, including antimicrobial, anticancer, and anti-inflammatory effects, and explored their potential in regulating cancer cell growth and drug development.", "population_specificity": "Not specified (literature review)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:10.895692+00:00"}
{"study_id": 56465, "supplement_id": 1114, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the biological activities and pharmacological applications of essential oils and their volatile components when complexed with cyclodextrins.", "results_summary": "The study found that essential oils and their volatile components complexed with cyclodextrins showed greater efficacy in in vitro and preclinical studies compared to their free forms, improving solubility, bioavailability, and pharmacological effects.", "population_specificity": "Preclinical (animal models) and in vitro studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:11.711905+00:00"}
{"study_id": 56469, "supplement_id": 1114, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and applicability of essential oils, among other treatments, for inactivating or killing Toxoplasma gondii in food intended for public consumption.", "results_summary": "The study assessed essential oils as part of chemical and biochemical treatments for T. gondii inactivation but did not provide specific efficacy results for essential oils alone.", "population_specificity": "Foodstuff intended for public consumption and experimental conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:11.741472+00:00"}
